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Abstract 
 The molecular mechanisms leading to axonal guidance are vital for the 
proper wiring of the nervous system. Many psychiatric disorders may arise from 
the improper development of the brain. If an axon does not form, or is extended 
to a place where it is not supposed to be, proper synapses will not form and 
communication between neurons and neighbor cells will be affected.  An axon is 
extended after the migration of the growth cone. Filopodia and lamellipodia are 
extended from the growth cone in order to sense the environment for guidance 
cues. Once signaled, the growth cone migrates to its final target and the axon is 
developed. A class of proteins called the Rac GTPases is essential for the 
process of axon pathfinding. 
In the model nematode Caenorhabditis elegans, MIG-2/RhoG and CED-
10/Rac1 are the two redundant Rac GTPases involved in growth cone migration. 
The main role of Rac GTPases in axon guidance is due to its control over the 
actin cytoskeleton. The actin-binding UNC-115/abLIM acts downstream of CED-
10/Rac1 in axon pathfinding. In Chapters II and III, I describe how Rac signaling 
activates UNC-115/abLIM. I propose that the scaffolding protein RACK-1 recruits 
UNC-115/abLIM to the plasma membrane and brings other molecules, such as 
PKC, for its modulation. 
Rac GTPases switch between an inactive, GDP-bound form, to an active, 
GTP-bound form. Activation can be aided by guanine-nucleotide exchange 
factors (GEFs), and inactivation is enhanced by GTPase activating proteins 
(GAPs). UNC-73/Trio is a GEF that acts with both MIG-2/RhoG and CED-
 iv 
10/Rac1 in axon guidance. Nevertheless, mutations that disrupt the Rac GEF 
activity of UNC-73/Trio do not affect axon pathfinding to the same levels as the 
abolishment of Rac activity seen in the double mutant of mig-2 and ced-10. Along 
with other evidence, this suggested that there were other molecules involved in 
the control of Rac GTPases in this process. 
I performed a candidate-based genetic screen in the C. elegans genome 
in order to find other DH-containing GEFs that could potentially interact with MIG-
2/RhoG and CED-10/Rac1. In Chapter IV, I show that the Rac GEF TIAM-1 acts 
upstream of MIG-2/RhoG and CED-10/Rac1 as a linker between these GTPases 
and CDC-42, another member of the Rho subfamily of small GTPases. 
Moreover, previous studies have implicated Rac GTPases, but not UNC-73/Trio, 
in the UNC-6/Netrin attractive signaling system. I show that TIAM-1 is the GEF 
recruited for this system. In Chapter V I show that other GEFs are also involved 
in this process. The Rac GEF PIX-1/βPIX, and two CDC-42 GEFs, UIG-1/Clg 
and EXC-5/FGD1, are also involved in the control of Rac GTPases during axon 
development. 
 In summary, my work has shown how Rac GTPases control the activity of 
the actin-binding protein UNC-115/abLIM, and how Rac GTPases themselves 
are controlled during the process of axon guidance. 
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Neurons are the main type of cells that constitute the nervous system. 
They are responsible for the storage and conduction of the electrical and 
chemical information necessary for the coordination and survival of an organism 
(Ghysen 2003). Neuronal cells are born out of neuroblasts, which are neuronal 
precursors that often migrate to a final destination and extend processes called 
neurites in order to contact other neurons or cells. Neurons typically consist of 
one or more dendrites (the neurites that typically receive information via chemical 
and electrical synapses), a cell body (which processes such information for 
further action), and one or more axons (which are the neurites that often conduct 
the processed information to synapse into a target cell) (Ghysen 2003). Neurites 
are formed early in neuron development. Neuroblasts typically polarize their 
intracellular machinery to determine where dendrites and axons will be formed. 
Once polarized, structures called growth cones are formed, and axons and 
dendrites start to develop (Marin, Valiente et al. 2010). In axon development and 
guidance, the growth cone protrudes lamellipodia (from Latin, sheet-like feet) and 
filopodia (thread-like feet) that are essential for its migration. These protrusions 
act as sensory and motile forces that guide the growth cone to its destination, 
leaving an extended neurite behind – the axon (Small, Stradal et al. 2002; Mattila 
and Lappalainen 2008). 
In order to create lamellipodia and filopodia, neurons have to rearrange 
their peripheral actin cytoskeletons. Actin monomers can be assembled together 
in different fashions: in filopodia, actin filaments are bundled together (Mattila and 
Lappalainen 2008), while in lamellipodia these filaments are arranged in a 70o 
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angle, creating an actin filament meshwork (Small, Stradal et al. 2002). Several 
actin-binding proteins, such as the Arp2/3 complex, Formins, UNC-115/abLIM, 
Capping and Anti-Capping proteins (i.e., UNC-34/Enabled) and many others 
have been previously implicated in protrusion formation and or dynamics 
(Korobova and Svitkina 2008; Matusek, Gombos et al. 2008; Norris, Dyer et al. 
2009). These actin-modulating proteins contribute to axon development and 
guidance in overlapping or specific ways. Actin nucleators, such as the Arp2/3 
complex, formins and possibly UNC-115/abLIM, contribute to protrusion 
formation by the polymerization of actin filaments. Arp2/3 nucleates actin 
filaments in a 70o angle from the sides of previously assembled filaments 
(Suetsugu, Miki et al. 2002; Korobova and Svitkina 2008). Formins associate with 
the fast growing end of actin filaments, promoting their extension (Evangelista, 
Zigmond et al. 2003). Though the precise role of the actin-binding protein UNC-
115/abLIM has not yet been determined, some evidence suggests it is a putative 
de novo actin filament nucleator (Lundquist, Herman et al. 1998; Garcia, Abbasi 
et al. 2007; Norris, Dyer et al. 2009; Demarco and Lundquist 2010). Capping and 
anti-capping proteins contribute to protrusion dynamics by regulating actin 
assembly in the growing tips of the filaments (Bashaw, Kidd et al. 2000; Aguda, 
Burtnick et al. 2005).  
A class of molecules that is vital for growth cone migration and the control 
of the actin cytoskeleton is the Rac GTPases (Dickson 2001). Racs are members 
of the Rho subfamily of small GTPases. This family consists of Rac (Ras-related 
C3 botulinium toxin substrate), Rho (Ras homology) and Cdc-42 (Cell division 
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control protein 42), and every member is active when bound to a guanosine 
triphosphate (GTP) molecule, and inactive when bound to a guanosine 
diphosphate (GDP) molecule (Hall 1992; Bishop and Hall 2000). Activation can 
be aided by Guanine-nucleotide Exchange Factors (GEFs), molecules that 
typically contain a Double Homology  (DH) domain (which are often followed by a 
Pleckstrin Homology [PH] domain). The DH domain of these molecules facilitates 
the exit of GDP from the GTP-binding pocket. Because the intracellular 
concentration of GTP is typically much higher than of GDP, a GTP molecule can 
enter the GTP-binding pocket of the GTPase and activate it. Rho GTPase 
inactivation can be aided by GTPase-Activating Proteins (GAPs), which enhance 
the intrinsic GTPase activity of Rho proteins, yielding in the hydrolysis of GTP 
into GDP and inorganic phosphate (Pi) (Schmidt and Hall 2002). 
Proper regulation of Rac GTPase activity is crucial for lamellipodial and 
filopodial formation (Dickson 2001). In vitro studies have demonstrated the role of 
these molecules and some of their effectors in cell migration and neuronal 
development (Dickson 2002). However, these studies often use dominant 
negative proteins, and they lack the relevant physiological environment that 
surrounds neurons as they grow. Therefore, an in vivo analysis of the modulators 
and effectors of Rac GTPases in the journey axons take to find their path could 
benefit our knowledge of what happens during this process. I took a cell 
biological, biochemical and genetic approach to characterize the molecules 
involved in the Rac signaling pathway used for axon guidance. The nematode 
Caenorhabditis elegans was used as a model organism for my genetic studies 
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for its several advantages (Brenner 1974; Coulson, Sulston et al. 1986; White, 
Southgate et al. 1986). These animals are relatively cheap to maintain, have a 
very brief generation cycle (of about 3 days), have hermaphrodite and male 
sexes (which enable geneticists to easily cross and maintain strains), are 
transparent (which allow for the use of microscopy without the need of fixation 
and dissection), and have their genomes sequenced and available on the 
Wormbase database, among other positive facts. In addition, the stereotyped C. 
elegans nervous system consists of virtually the same types of neurons higher 
organisms have (including humans), and the molecules involved in neuronal 
development (for instance, Rac GTPases) are quite well conserved among 
species . Figure 1.1 demonstrates what was known about Rac GTPase 
modulators and effectors in C. elegans axon pathfinding prior and after this work. 
I was able to elucidate some of the mechanisms utilized by Rac GTPases to 
modulate the activity of the novel actin-binding protein UNC-115/abLIM 
(Chapters II and III). In addition, we also uncovered the roles of different 
activators of the Rac GTPase pathway during growth cone migration (Chapters 
IV and V). 
Prevalent human neurological disorders such as autism, epilepsy and 
dyslexia could have their roots in the improper wiring of the nervous system. 
Small changes in expression of ROBO1, a guidance receptor involved in neurite 
guidance, are implicated in human dyslexia (Hannula-Jouppi, Kaminen-Ahola et 
al. 2005).  The ROBO family of transmembrane receptors has also been involved 
in the modulation of the serotonin receptor SerT, a molecule in which 
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polymorphisms have been associated with the development of autism (Anitha, 
Nakamura et al. 2008). Changes in the expression levels of netrin-G2, a 
membrane-bound guidance molecule, have been implicated in temporal lobe 
epilepsy in rats and humans (Pan, Liu et al.). Hence a better understanding of 
the molecular pathways involved in modulating the actin cytoskeleton is of 
extreme importance for the study of neurodevelopment. 
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Figure 1.1 
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Figure 1.1. A representation of the molecules known to participate in the 
reassembly of the actin cytoskeleton during growth cone migration. A. 
Before our work, the only GEF known to regulate MIG-2/RhoG and CED-10/Rac 
was UNC-73/Trio. Not much was known about how CDC-42 interacts with Racs, 
nor how CED-10/Rac activated UNC-115/abLIM. B. After our work, new 
molecules were involved in the proper control of axon guidance. In both 
drawings, actin filaments are represented by small gray circles bundled together. 
The plasma membrane of the growth cone is surrounding all molecules. 
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Chapter II 
RACK-1 acts cell autonomously with Rac GTPase signaling and UNC-
115/abLIM in C. elegans axon pathfinding and cell migration 
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2.1 Abstract 
Migrating cells and growth cones extend lamellipodial and filopodial protrusions 
that are required for outgrowth and guidance.  The mechanisms of cytoskeletal 
regulation that underlie cell and growth cone migration are of much interest to 
developmental biologists.  Previous studies have shown that the Arp2/3 complex 
and UNC-115/abLIM act redundantly to mediate growth cone lamellipodia and 
filopodia formation and axon pathfinding.  While much is known about the 
regulation of Arp2/3, less is known about regulators of UNC-115/abLIM.  Here we 
show that the C. elegans counterpart of the Receptor for Activated C Kinase 
(RACK-1) interacts physically with the actin-binding protein UNC-115/abLIM, and 
that RACK-1 is required for axon pathfinding.  Genetic interactions indicate that 
RACK-1 acts cell autonomously in the UNC-115/abLIM pathway in axon 
pathfinding and lamellipodia and filopodia formation, downstream of the CED-
10/Rac GTPase and in parallel to MIG-2/RhoG.  Furthermore, we show that 
RACK-1 is involved in migration of the gonadal distal tip cells, and that the 
signaling pathways involved in this process might be distinct from those involved 
in axon pathfinding.  In sum, these studies pinpoint RACK-1 as a component of a 
novel signaling pathway involving Rac GTPases and UNC-115/abLIM, and 
suggest that RACK-1 might be involved in the regulation of the actin cytoskeleton 
and lamellipodia and filopodia formation in migrating cells and growth cones.  
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2.2 Introduction 
 The actin cytoskeleton is necessary for the formation of cellular 
protrusions, lamellipodia and filopodia, that underlie morphogenetic events such 
as cell migration and axon pathfinding (Welch, Mallavarapu et al. 1997; Borisy 
and Svitkina 2000; Pollard and Borisy 2003; Gallo and Letourneau 2004).  
Unraveling the complex molecular events that regulate actin structure and 
dynamics in migrating cells and growth cones will be central to understanding the 
development of multicellular organisms and the nervous system in particular.  
Migrating cells and growth cones display dynamic lamellipodial and filopodial 
protrusions consisting of a meshwork of actin filaments and bundles of actin 
filaments, respectively (Welch and Mullins 2002; Svitkina, Bulanova et al. 2003; 
Gallo and Letourneau 2004; Korobova and Svitkina 2008; Pak, Flynn et al. 
2008).  Lamellipodia and filopodia serve to guide cells and growth cones and 
also provide in part the motile force necessary for cell migration and growth cone 
advance (Zhou and Cohan 2004).  A complex interplay of filopodial and 
lamellipodial dynamics controlled by guidance receptors and their ligands is the 
basis for guidance outgrowth and migration. 
 In cultured cells, the actin-nucleating Arp2/3 complex controls the 
formation of lamellipodial networks (Svitkina and Borisy 1999; Borisy and 
Svitkina 2000; Beltzner and Pollard 2007), whereas the anti-capping protein 
Enabled controls filopodial formation (Lebrand, Dent et al. 2004; Barzik, Kotova 
et al. 2005).  Enabled also affects axon pathfinding in C. elegans (Withee, 
Galligan et al. 2004; Shakir, Gill et al. 2006).  In migrating growth cones in C. 
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elegans, the Arp2/3 complex is required for both lamellipodial and filopodial 
formation (Norris, Dyer et al. 2009), likely due to the contribution of Arp2/3-
nucleated actin filaments to filopodial bundles (Korobova and Svitkina 2008).  
The actin-binding protein UNC-115/abLIM (Lundquist, Herman et al. 1998) also 
controls lamellipodial and filopodial formation in C. elegans growth cones (Norris, 
Dyer et al. 2009), and acts in parallel to the Arp2/3 complex in axon pathfinding 
(Lundquist, Herman et al. 1998; Shakir, Jiang et al. 2008; Norris, Dyer et al. 
2009), indicating that UNC-115/abLIM may be contributing to both lamellipodial 
and filopodial formation in growth cones.  The signaling pathways that control 
Arp2/3 activation are well documented.  The Arp2/3 activators WASP and WAVE 
act downstream of Cdc42 and Rac GTPases respectively to regulate Arp2/3 
activity (Miki, Suetsugu et al. 1998; Eden, Rohatgi et al. 2002; Miki and 
Takenawa 2003; Innocenti, Zucconi et al. 2004; Beltzner and Pollard 2007).  In 
C. elegans axon pathfinding, WVE-1/WAVE acts downstream of CED-10/Rac 
and WSP-1/WASP acts downstream of the MIG-2/RhoG GTPase to regulate 
Arp2/3 (Shakir, Jiang et al. 2008).    
 While much is known about the Arp2/3 signaling pathway, less is known 
about the control of UNC-115/abLIM in lamellipodia and filopodia formation.  The 
conserved UNC-115/abLIM proteins have multiple LIM domains at the N 
terminus and an actin-binding villin headpiece domain at the C terminus (Roof, 
Hayes et al. 1997; Lundquist, Herman et al. 1998; Garcia, Abbasi et al. 2007).  
The central region of the molecule contains a short region of similarity shared 
with the dematin protein, which also contains a C terminal actin-binding villin 
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headpiece domain.  Previous studies in C. elegans showed that UNC-115/abLIM 
acts downstream of the CED-10/Rac GTPase in neuronal lamellipodia and 
filopodia formation (Struckhoff and Lundquist 2003).  The conserved seven-WD 
repeat molecule SWAN-1 physically interacts with the UNC-115 LIM domains 
and with Rac GTPases, and is normally required to attenuate Rac GTPase 
signaling (Yang, Lu et al. 2006), indicating that SWAN-1 might be a link between 
Rac signaling and UNC-115/abLIM. 
 A two-hybrid screen with the central region of UNC-115 identified the C. 
elegans Receptor for Activated C Kinase molecule (Rack1), called RACK-1 in C. 
elegans (Mochly-Rosen, Khaner et al. 1991; Ai, Poole et al. 2009).  Rack1 
molecules are composed of seven WD repeats, which form a seven-bladed beta 
propeller structure that serves as a scaffold for protein-protein interactions (Neer, 
Schmidt et al. 1994).  Rack1 was first identified as a molecule that bound to 
activated protein kinase C and mediated its plasma membrane translocation 
(Ron, Chen et al. 1994; Besson, Wilson et al. 2002).  Further studies have shown 
that Rack1 acts with a very diverse set of signaling complexes and can mediate 
their sub cellular distributions and shuttling (reviewed in (Sklan, Podoly et al. 
2006)).  This diversity of interaction leads to a diversity of function for Rack1, 
including transcriptional and translational regulation, regulation of membrane 
trafficking, regulation of signal transduction, and cell adhesion (Sklan, Podoly et 
al. 2006).  Interestingly, Rack1 controls cell motility via its interaction with the Src 
tyrosine kinase (Liliental and Chang 1998; Besson, Wilson et al. 2002).  Rack1 is 
a substrate for Src tyrosine phosphorylation and acts as a repressor of Src in 
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response to active PKC (Chang, Conroy et al. 1998; Buensuceso, Woodside et 
al. 2001; Schechtman and Mochly-Rosen 2001; Besson, Wilson et al. 2002; 
Chang, Harte et al. 2002).  Rack1 inhibits Src-induced cell motility in cultured 3T3 
fibroblasts, and inhibits Src phosphorylation of p190RhoGAP (Miller, Lee et al. 
2004), a modulator of Rho GTPase signaling and actin organization.  Rack1 is 
also phosphorylated on tyrosine 52 by c-Abl, which is involved in Rack1 
regulation of focal adhesion kinase and integrin function (Kiely, Baillie et al. 
2009).  In C. elegans, RACK-1 has been shown to be involved in embryonic 
cytokinesis (Ai, Poole et al. 2009).  C. elegans RACK-1 regulates membrane 
trafficking and recycling endosome distribution via interaction with dynactin, and 
thus might regulate the microtubule motor dynein.  As a consequence, rack-1 
loss of function leads to defects in cytokinesis and chromosome separation in the 
early embryo. 
 Here we show that RACK-1 interacts with the actin-binding protein UNC-
115/abLIM, and that RACK-1 is required for axon pathfinding.  Genetic 
interactions indicate that RACK-1 acts in the UNC-115/abLIM pathway in axon 
pathfinding, downstream of the CED-10/Rac GTPase and in parallel to MIG-
2/RhoG and the UNC-34/Enabled.  Neuron-specific expression of RACK-1 is 
sufficient to rescue the axon pathfinding defects of rack-1 mutants, indicating that 
RACK-1 acts cell autonomously in axon pathfinding.  Furthermore, we show that 
RACK-1 is involved in migration of the gonadal distal tip cells, and that the 
signaling pathways involved in this process might be distinct from those involved 
in axon pathfinding.  In sum, these studies pinpoint RACK-1 as a component of a 
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signaling pathway involving Rac GTPases and UNC-115/abLIM, and suggest 
that RACK-1 might be involved in the regulation of the actin cytoskeleton and 
lamellipodia and filopodia formation in migrating cells and growth cones. 
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2.3 Results 
 
RACK-1 interacts with UNC-115/abLIM in a yeast two-hybrid screen. The 
actin-binding protein UNC-115/abLIM has three LIM domains in the N-terminus, a 
villin headpiece domain (VHD) in the C-terminus, and a middle region with 
unknown function that contains a highly conserved region across species, the 
UAD domain (UNC-115, abLIM, dematin) (Figure 1A) (Lundquist, Herman et al. 
1998).  The VHD physically interacts with F-actin (Roof, Hayes et al. 1997; 
Struckhoff and Lundquist 2003), while the LIM domains are thought to mediate 
protein-protein interactions.  Previous studies showed that the seven WD-repeat 
protein SWAN-1, a negative regulator of UNC-115 activity, interacts with the LIM 
domains of UNC-115 (Yang, Lu et al. 2006). 
 In order to identify molecules that interact physically with the non-LIM-
domain region UNC-115, the central region of UNC-115 (residues 243 to 553 of 
the F09B9.2b molecule as described on Wormbase) was used as bait in a yeast 
two-hybrid screen (Figure 1A).  This two-hybrid screen was performed at the 
Molecular Interaction Facility at the University of Wisconsin-Madison.  The 
screen involved activation of β-galactosidase activity and HIS5 expression in a 
liquid-based microtiter screening procedure (see Materials and Methods).  From 
a total of 36 million C. elegans poly-A primed cDNAs screened, seven cDNAs 
that corresponded to the K04D7.1 gene (as annotated on Wormbase) were 
found.  All seven cDNAs were found to activate when retested, and all seven 
cDNAs displayed bait-dependence and did not activate in the absence of the 
UNC-115 bait (data not shown). 
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 The seven cDNAs represented five independent isolates (i.e. represented 
five different 5’ ends), with two of the isolates having two representatives each 
(Figure 1E).  Three of the cDNAs contained the entire predicted K04D7.1 open 
reading frame, and two were missing some of the predicted 5’ open reading 
frame.  All five cDNAs were in frame to the GAL4 activation domain in the pACT 
two-hybrid vector.  
 The K04D7.1 cDNAs were predicted to encode a molecule similar to 
vertebrate Receptor for Activated C Kinase (Rack1), called RACK-1 in C. 
elegans (Figures 1D and E) (Ai, Poole et al. 2009).  RACK-1 is predicted to 
contain seven WD repeats that form a seven-bladed beta-propeller similar to the 
beta subunit of G proteins (Sondek, Bohm et al. 1996).  Rack1 molecules define 
a conserved family of seven-WD repeat proteins, and are distinct from other 
families such as Gβ and AN11/SWAN-1 (Sondek, Bohm et al. 1996; Yang, Lu et 
al. 2006).  Rack1 molecules are defined by two conserved regions that interact 
with protein kinase C, a conserved tyrosine residue that is phosphorylated by the 
Src tyrosine kinase, and a tyrosine residue at position 52 that is phosphorylated 
by c-Abl.  The PKC interaction sites and the Src phosphorylated tyrosine are 
conserved in the C. elegans RACK-1 protein, but the c-Abl phosphorylated 
tyrosine at position 52 in human Rack1 is not present in C. elegans RACK-1 
(Figure 1E).  Two of the cDNAs isolated in the two-hybrid screen were missing 
coding region for the first predicted WD repeat and one of them was missing part 
of the second predicted WD repeat (Figure 1E). 
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UNC-115 co-immunoprecipitated with RACK-1.  To confirm that RACK-1 and 
UNC-115 interact in a complex, we determined if RACK-1 and UNC-115 co-
immunoprecipitated from C. elegans extracts.  We generated a transgene 
expressing MYC-tagged RACK-1 under its endogenous promoter and made 
animals transgenic for this construct.  This transgene produced functional RACK-
1::MYC, as it rescued the sterility, gonadal distal tip cell migration defects, and 
axon pathfinding defects caused by the rack-1(tm2262) deletion (see below).  We 
immunoprecipitated MYC-tagged RACK-1 (RACK-1::MYC) using an anti-MYC 
antibody from animals harboring a rack-1::myc integrated gene (see Materials 
and Methods).  Using anti-MYC western blots, we found that RACK-1::MYC (36 
kD) was expressed in C. elegans extracts and that it was immunoprecipitated by 
this treatment (Figure 1B).  Western blots using anti-UNC-115 antibody (Yang, 
Lu et al. 2006) showed the specific co-immunoprecipitation of UNC-115 (72 kD) 
with RACK-1::MYC (Figure 1B).  In the absence of the anti-MYC antibody, 
RACK-1::MYC did not precipitate, and neither did UNC-115 (Figure 1B).  
Furthermore, we could detect no UNC-115 when extracts from C. elegans not 
expressing RACK-1::MYC were immunoprecipitated with the MYC antibody (data 
not shown).  We repeated this co-immunoprecipitation two additional times, and 
the results of one representative experiment are shown in Figure 1. 
 
rack-1 is required for axon pathfinding.  C. elegans RACK-1 is a 325 amino-
acid protein that has two regions similar to the PKC binding sites of vertebrate 
RACK and a conserved tyrosine that is phosphorylated by Src in vertebrate 
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RACK.  C. elegans PKC and Src isoforms are expressed in the nervous system, 
and both PKC and Src have been implicated in growth cone pathfinding and cell 
migration (Tabuse 2002; Itoh, Hirose et al. 2005).  Furthermore, we show above 
that RACK-1 interacts with UNC-115, a molecule that controls axon pathfinding in 
C. elegans (Lundquist, Herman et al. 1998).  Thus, we determined if RACK-1 
was also involved in axon pathfinding in C. elegans. 
 The VD and DD motor neurons are GABAergic neurons that control the 
coordination and movement of the nematode (White, Southgate et al. 1986; 
McIntire, Jorgensen et al. 1993).  The VD and DD cell bodies reside on the right 
side of the ventral nerve cord.  Axons extend anteriorly, branch, and extend 
dorsally to form axon commissures (Figure 2).  Upon reaching the dorsal cord, 
the axons branch again and extend posteriorly and anteriorly.  We used an unc-
25::gfp transgene (juIs76) to image the VD/DD neurons and their axons (Jin, 
Jorgensen et al. 1999).  unc-115(ky275) disrupts axon pathfinding in these 
neurons, yielding in an uncoordinated movement phenotype (Lundquist, Herman 
et al. 1998).  We perturbed rack-1 function using RNAi by injection (see Materials 
and Methods).  In 22% of injected animals (n > 100), rack-1(RNAi) disrupted the 
proper pathfinding of the VD and DD commissural axons (Figures 2A and B). The 
defects seen, such as axon misguidance, branching and premature termination, 
resembled the defects observed in unc-115(ky275) (Lundquist, Herman et al. 
1998) and were never observed in wild-type animals.  These results suggest that 
RACK-1 might be involved in axon pathfinding, similar to UNC-115. 
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 A deletion of the rack-1 locus, called tm2262, was isolated and kindly 
provided by the National Bioresource Project for the Experimental Animal 
“Nematode C. elegans” (S. Mitani).  The tm2262 deletion was an in-frame 
deletion that removed part of the first WD repeat, all of the second, and most of 
the third, including the predicted PKC interaction site in WD3 (Figures 1C-E).  
Since tm2262 is an in-frame deletion, tm2262 animals might still produce 
truncated RACK-1 protein and rack-1(tm2262) might be a hypomorph.  However, 
RNAi did not worsen the low brood size or axon defects of rack-1(tm2262) (see 
below; data not shown), indicating that it might be a strong loss of function allele. 
 Similar to RNAi of rack-1, the deletion allele rack-1(tm2262) caused 
pathfinding defects in the VD and DD motor neurons (Figure 2).  Normally, all 
VD/DD commissures extend on the right side of the animal except DD1/VD2, 
which form a single commissure in the anterior (arrow in Figure 2C).  rack-
1(tm2262) displayed VD/DD commissures aberrantly extending up the left side of 
the animal (Figure 1D), and VD/DD axons that were misguided on their dorsal 
migrations (Figure 1D).  In our hands, 27% of wild type animals harboring the 
unc-25:gfp transgene juIs76 had VD/DD commissures on the left side in addition 
to DD1/VD2.  However, 60% of rack-1(tm2262); juIs76 showed VD/DD 
commissures on the left side (p < 0.001) (Figure 3).  In juIs76 animals, generally 
only one or two left-side VD/DD were observed, whereas multiple axons on the 
left side were often observed in rack-1(tm2262); juIs76 animals (Figure 2D).  In 
addition, 42% of rack-1(tm2262); juIs76 animals displayed VD/DD axon guidance 
and outgrowth defects such as axonal wandering, branching or termination 
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(Figure 3), whereas  juIs76 alone showed no strong defects but did display some 
minor axon wandering. 
 To ensure that the axon guidance defects observed in rack-1(tm2262) 
were due to rack-1 perturbation and not a background mutation, we rescued the 
VD/DD axon defects with a rack-1::myc transgene. rack-1::myc rescued both left-
right defects and commissural guidance defects (60% to 32% (p < 0.001) and 
42% to 10% (p < 0.001)) (Figure 3).  Together, these results indicate that RACK-
1 is required for VD/DD axon pathfinding. 
 
rack-1(tm2262) caused reduced brood size. rack-1(tm2262) animals were 
slow growing and had very low brood size.  In a progeny count, ten wild-type and 
ten rack-1(tm2262) animals were individually plated and then transferred to a 
new plate every day until egg-laying ceased.  The number of viable adult progeny 
resulting from each animal were counted and averaged. The average progeny 
count for a wild-type N2 animal was of 278.4 (s.d.=32.72), while for rack-
1(tm2262) the count dropped to 23.3 (s.d.=9.9) (p < 0.0001).  A transgene 
containing the rack-1 gene under its native promoter fused to the gfp coding 
region (rack-1::gfp) (see Materials and Methods) increased brood size in rack-
1(tm2262) animals to 73.78 (s.d.=17.18) (p < 0.0001), suggesting that rack-1::gfp 
was functional and could rescue the brood size defect in rack-1 animals.  rack-
1::myc could also rescue the low brood size of rack(tm2262) (data not shown).  
Thus, the reduction in brood size was due to rack-1 and not due to genetic 
background in the tm2262 strain. 
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 The reduced brood size of rack-1(tm2262) seems to be predominantly  
due to decreased production of fertilized embryos.  rack-1 might affect oogenesis 
or spermatogenesis, but the nature of this sterility has not been explored.  
Previous studies indicate that rack-1 also affects embryogenesis by regulating 
membrane trafficking and recycling endosome distribution via interaction with 
dynactin to control cytokinesis and chromosome separation in the early embryo 
(Ai, Poole et al. 2009). 
 
rack-1::gfp was expressed in most tissues, including neurons and the 
distal tip cells.  In order to determine where the rack-1 gene is expressed, we 
constructed a reporter transgene consisting of the promoter region of rack-1 
fused to the gfp coding region (see Materials and Methods).  rack-1 promoter::gfp 
was expressed in most if not all tissues.  Due to mitotic loss of the transgene-
bearing extrachromosomal array, we were able to analyze rack-1 promoter::gfp 
expression in mosaic animals in which we could discern specific cell types.  rack-
1 promoter::gfp was expressed in neurons as well as the distal tip cells of the 
gonad (Figures 4A and B). 
 In order to determine the subcellular localization of RACK-1 protein, we 
constructed a full-length rack-1::gfp fusion.  This transgene is predicted to 
encode a full-length RACK-1 protein with GFP at the C-terminus (RACK-1::GFP).   
rack-1::gfp rescued the sterility and gonadal distal tip cell migration defects of 
rack-1(tm2262) mutants.  RACK-1::GFP was present in the cytoplasm of cells 
and showed little if any nuclear accumulation (Figures 4C and D), although low 
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levels of RACK-1::GFP in the nucleus cannot be excluded.  RACK-1::GFP was 
present in the growth cones of extending VD commissural axons, but was 
present in the axons and cell bodies as well (Figure 5A and B). 
 
rack-1 acts cell-autonomously in the VD/DD neurons to control axon 
pathfinding.  rack-1 was expressed in most if not all tissues in the animal, 
including neurons.  To determine if RACK-1 is required in the VD/DD neurons 
themselves for axon pathfinding, we drove expression of rack-1::gfp specifically 
in the VD/DD neurons using the GABAergic neuron-specific unc-25 promoter. 
The wild-type rack-1(+) coding region lacking the upstream promoter region was 
fused to gfp downstream of the unc-25 promoter.  The Ex[unc-25 promoter::rack-
1::gfp] transgene was expressed specifically in the GABAergic neurons including 
the VD/DD neurons and nowhere else (Figure 5A).  This transgene did not 
rescue the fertility defects and DTC migration defects of rack-1(tm2262) as did 
the genomic rack-1(+) transgene (data not shown), indicating that expression 
was specific to the VD/DD neurons.  Ex[unc-25 promoter::rack-1(+)] rescued the 
lateral asymmetry defects and axon wandering defects of rack-1(tm2262) 
animals (Figure 3) (60% to 33% for lateral asymmetry defects and 16% to 8% for 
axon wandering defects; p < 0.001 in both cases).  In this experiment, individual 
axons were scored, due to the mosaic nature of the Ex[unc-25 promoter::rack-
1(+)] transgene.  These data indicate that rack-1 acts cell autonomously in 
neurons in axon pathfinding. 
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rack-1(tm2262) enhanced mig-2(mu28) and unc-34(e951) but not unc-
115(ky275) or ced-10(n1993) in PDE axon pathfinding.  The above results 
show that RACK-1 physically interacted with UNC-115/abLIM and that rack-1 
loss of function caused axon pathfinding defects similar to unc-115.  Previous 
studies showed that UNC-115/abLIM acts downstream of the Rac GTPase CED-
10/Rac and in parallel to MIG-2/RhoG in axon pathfinding (Lundquist 2003; 
Struckhoff and Lundquist 2003).  We next set out to determine if RACK-1 
interacts with UNC-115/abLIM and the Rac GTPases in axon pathfinding.  To 
analyze genetic interactions between these molecules, we used the PDE 
neurons, which are located at the post-deiridic region of the animal.  These 
neurons are a good model for axon pathfinding since the reporter construct osm-
6::gfp is expressed only in the PDEs in the post-deirid (Collet, Spike et al. 1998; 
Struckhoff and Lundquist 2003), allowing unambiguous identification and scoring 
of the simple PDE axon morphology.  Furthermore, the defects in PDE axon 
pathfinding in single mutants were weak, allowing for discrimination of genetic 
interactions in double mutants. 
 In wild-type, the PDE cell body extends an axonal projection toward the 
ventral nerve cord in a straight line, where the axon then branches and extends 
anteriorly and posteriorly (Figure 6A) (White, Southgate et al. 1986).  Pathfinding 
defects were defined as axons that were prematurely terminated or that 
wandered at a greater than 45 degree angle relative to the normal PDE axon (for 
example, Figure 6B).  As shown previously, mig-2(mu28), ced-10(n1993), and 
unc-115(ky275), alone had low-penetrance defects in PDE axon pathfinding on 
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their own (3%-7%; Figure 6C).  We found that rack-1(tm2262) also had very few 
defects in PDE axon pathfinding (1%; Figure 6C). 
 Previous results show that CED-10/Rac and MIG-2/RhoG act redundantly 
in PDE axon pathfinding, and UNC-115/abLIM works downstream of CED-
10/Rac, in parallel to MIG-2/RhoG in PDE pathfinding (Lundquist, Reddien et al. 
2001; Struckhoff and Lundquist 2003).  If RACK-1 works in the same pathway as 
UNC-115/abLIM, we expect that loss of function of both rack-1 and unc-115 
would be no more severe than either mutant alone.  Indeed, rack-1(tm2262M+); 
unc-115(ky275) double mutants (M+ denotes that the homozygous animal was 
derived from a balanced heterozygote and has wild-type maternal contribution) 
displayed levels of PDE axon pathfinding defects (6%; Figure 6C) that were not 
significantly different from unc-115(ky275) and rack-1(tm2262) alone, suggesting 
that UNC-115/abLIM and RACK-1 might act in the same pathway.  In contrast, 
rack-1(tm2262M+); mig-2(mu28) double mutants showed significantly increased 
levels of defects compared to either single alone (28%; Figure 6C).  This result 
demonstrates that rack-1(tm2262) can synergize with other mutants to cause 
axon defects, and that RACK-1 and MIG-2/RhoG might act in parallel pathways 
in axon pathfinding. 
 CED-10/Rac and UNC-115/abLIM have previously been shown to act in 
the same pathway in parallel to MIG-2/RhoG (Struckhoff and Lundquist 2003).  
rack-1(tm2262M+) ced-10(n1993M+) double mutants displayed no significant 
increase in PDE defects compared to either single alone (6%; Figure 6C), 
consistent with the idea that RACK-1, CED-10/Rac, and UNC-115/abLIM act in a 
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common pathway in parallel to MIG-2/RhoG in axon pathfinding.  If this is the 
case, we would expect the rack-1(tm2262M+) ced-10(n1993M+); unc-115(ky275) 
triple mutant to be no more severe than any double mutant combination alone.  
As previously reported, ced-10(n1993); unc-115(ky275) double mutants were 
significantly more severe than either single alone (35%; Figure 6C) (Lundquist, 
Reddien et al. 2001; Struckhoff and Lundquist 2003).  This is likely due to the fact 
that CED-10/Rac also regulates the Arp2/3 complex in parallel to UNC-
115/abLIM (Shakir, Jiang et al. 2008; Norris, Dyer et al. 2009).  rack-
1(tm2262M+) ced-10(n1993M+) mutants did not show this interaction.  Possibly, 
RACK-1 is not the only molecule regulating UNC-115 and has a weaker effect.  
In any case, the rack-1(tm2262M+) ced-10(n1993M+); unc-115(ky275) triple 
mutant was not significantly more severe than ced-10(n1993); unc-115(ky275) 
alone (34% compared to 35%; Figure 6C).  Taken together, these results are 
consistent with the idea that RACK-1, CED-10/Rac, and UNC-115/abLIM act in a 
common pathway in axon pathfinding in parallel to MIG-2/RhoG. 
 UNC-34/Enabled has been shown to act in parallel to both CED-10/Rac 
and MIG-2/RhoG in axon pathfinding (Shakir, Gill et al. 2006).  Indeed, rack-
1(tm2262M+); unc-34(e951M+) double mutants displayed significantly increased 
pathfinding defects compared to unc-34(e951) alone (35% compared to 19%; 
Figure 6C).  This result indicates that RACK-1 acts in parallel to UNC-34/Enabled 
and is consistent with RACK-1 acting with CED-10/Rac and UNC-115/abLIM in 
axon pathfinding. 
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rack-1(tm2262) partially suppressed axon pathfinding defects and ectopic 
lamellipodia induced by activated CED-10(G12V).  Loss-of-function studies 
described above provide evidence that RACK-1 might act with CED-10/Rac and 
UNC-115/abLIM in axon pathfinding.  In order to further test the relationship 
between RACK-1 and the Rac GTPases we next asked what effect rack-
1(tm2262) loss of function might have on overactive Rac GTPases.  
Constitutively-activated Rac GTPases transgenes harbor a guanine-12-valine 
mutation in the GTPase binding pocket, which favors the active GTP-bound state 
of the GTPases.  Previous studies showed that CED-10(G12V) and MIG-
2(G16V) (the G12V equivalent) both caused axon pathfinding defects and drove 
the formation of ectopic neurites, lamellipodia, and filopodia when expressed in 
PDE neurons (Figure 7A), and that UNC-115/abLIM was required for ectopic 
lamellipodia and filopodia induced by CED-10(G12V) but not MIG-2(G16V) 
(Struckhoff and Lundquist 2003). 
 We determined if RACK-1 was required for the effects of CED-10(G12V) 
and MIG-2(G16V).  CED-10(G12V) alone caused 66% of PDE neurons to have 
ectopic lamellipodia and filopodia in young adults (Figure 7B).  rack-1(tm2262); 
ced-10(G12V) animals displayed 45% ectopic lamellipodia and filopodia, a 
significant reduction (p = 0.004) from CED-10(G12V) alone (Figure 7B).  These 
data indicate that rack-1(tm2262) partially suppressed activated CED-10(G12V) 
and that functional RACK-1 might be required for the formation of ectopic 
lamellipodia and filopodia induced by activated CED-10.  In contrast, rack-
1(tm2262) did not suppress ectopic lamellipodia and filopodia associated with 
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MIG-2(G16V) and in fact slightly enhanced these defects (Figure 7B; p = 0.03), 
indicating that this suppression is specific to CED-10(G12V).  These effects are 
similar to those observed with the wve-1/WAVE mutant, which suppressed CED-
10(G12V) and slightly enhanced MIG-2(G16V) (Shakir, Jiang et al. 2008).  These 
data are consistent with the idea that RACK-1 acts downstream of CED-10/Rac 
in parallel to MIG-2/RhoG in axon pathfinding, similar to UNC-115/abLIM. 
 rack-1(tm2262) did not suppress defects induced by activated 
myr::unc-115.  Previous studies showed that UNC-115 tagged with an N-
terminal myristylation sequence (MYR) caused activation of the molecule (Yang 
and Lundquist 2005).  MYR::UNC-115 localized to the plasma membrane and 
other membranes as expected for a myristylated protein and induced the 
formation of ectopic lamellipodia, filopodia and neurites in C. elegans neurons 
and in cultured mammalian fibroblasts (Yang and Lundquist 2005).  The 
formation of these ectopic lamellipodia and filopodia was dependent upon the 
actin-binding domain of UNC-115, suggesting that the molecule was 
constitutively active (Yang and Lundquist 2005). 
 To further dissect the interaction of RACK-1 with UNC-115, we assayed 
the effects of MYR::UNC-115 in a rack-1(tm2262) loss of function background.  
MYR::UNC-115 was expressed from the unc-115 promoter (the lqIs62 
transgene), which drives expression in most neurons including PDE and the 
VD/DDs (Yang and Lundquist 2005).  The myr::unc-115 transgene scored in 
(Yang and Lundquist 2005) was maintained as an extrachromosomal array.  We 
integrated this transgene into the genome for these studies (lqIs62).  We found 
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that lqIs62[MYR::UNC-115] caused 8% ectopic lamellipodia and filopodia in PDE 
neurons (Figure 7B), similar to but weaker than the extrachromosomal array 
effects reported in (Yang and Lundquist 2005).  The ectopic lamellipodia and 
filopodia induced by MYR::UNC-115 were not significantly altered by rack-
1(tm2262) mutation (Figure 7B), indicating that RACK-1 is not required for 
lamellipodia and filopodia induced by MYR::UNC-115.  This result suggests that 
RACK-1 might act upstream of UNC-115 or together with UNC-115, or that the 
MYR::UNC-115 molecule acts independently of RACK-1 activity. 
 To study the interactions of rack-1 with myr::unc-115 in more detail, we 
analyzed the VD/DD motor neurons as described above.  myr::unc-115 
expression caused left-right lateral asymmetry defects and commissural axon 
pathfinding defects as described for rack-1(tm2262) in Figures 2 and 3 (Figure 
8A).  rack-1(tm2262); myr::unc-115 animals displayed lateral asymmetry defects 
similar to each alone (Figure 8A; 45%-55%, not significant).  This is consistent 
with RACK-1 acting upstream of or together with UNC-115 in the same pathway.  
In VD/DD commissural axon pathfinding, rack-1(tm2262); myr::unc-115 displayed 
significantly increased defects compared to the additive effects of each alone 
(Figure 8A).  Thus, rack-1(tm2262) might enhance myr::unc-115 in VD/DD 
pathfinding. 
 In summary, we detected no strong suppression of myr::unc-115 by rack-
1(tm2262) in the PDE neurons and the VD/DD neurons.  The results are 
consistent with RACK-1 acting upstream of or together with UNC-115 in axon 
pathfinding.  Some context-specific interactions were observed, such as rack-
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1(tm2262) enhancing VD/DD commissural axon pathfinding, indicating that 
RACK-1 and UNC-115 might have distinct interactions in different contexts or 
developmental events. 
 
UNC-115 is required for the ectopic lamellipodia induced by MYR::RACK-1.  
The above results indicate that RACK-1 is not required for the effects of 
MYR::UNC-115, suggesting that RACK-1 might act upstream of UNC-115.  To 
test this idea, we constructed a myristylated version of RACK-1, similar to 
MYR::UNC-115.  We reasoned that constitutive membrane localization might 
activate RACK-1 as it does UNC-115.  myr::rack-1::gfp was expressed in the 
PDE neurons by the osm-6 promoter.  MYR::RACK-1::GFP displayed a 
membrane-associated distribution (arrowhead in Figure 9A), as did MYR::UNC-
115 (Yang and Lundquist 2005).  MYR::RACK-1 animals displayed ectopic 
lamellipodial protrusions along the cell body, dendrite, and axon, similar to 
MYR::UNC-115 and activated Rac GTPases (arrow in Figure 9A).  The putative 
null unc-115 alleles ky275 and ky274 suppressed this effect (11% in myr::rack-1 
reduced to 0% and 4% in unc-115(ky275); myr::rack-1 and unc-115(ky274); 
myr::rack-1, respectively) (Figure 9B).  The hypomorphic unc-115(mn481) allele 
(Lundquist, Herman et al. 1998), which retains some UNC-115 activity, did not 
suppress myr::rack-1, indicating that possibly only a small amount of UNC-115 
activity is required for MYR::RACK-1 to drive ectopic lamellipodia.  These studies 
support the model that RACK-1 acts upstream of UNC-115 in lamellipodia 
formation. 
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 Despite the strong genetic interactions of rack-1 and unc-115, we could 
detect no change in distribution of UNC-115::GFP in loss of function rack-
1(tm2262) or in the activated myr::unc-115 transgenics (data not shown).  In 
each case, UNC-115::GFP was present uniformly throughout the cytoplasm, 
similar to wild-type animals, and showed no membrane localization.  
 
rack-1(tm2262) suppresses myr::unc-115 in VD cell body position.  
Activated myr::unc-115 caused lateral displacement of GABAergic motor neuron 
cell bodies such that they often were found outside of the ventral nerve cord 
(Figure 8B).  The VD GABAergic neurons are descendants of the P cells.  The P 
cells are born laterally and the P nuclei migrate ventrally to the ventral nerve 
cord, where the P cells divide to produce ventral hypodermal cells including the 
vulva and the ventral VD neurons (Sulston and Horvitz 1977; White, Southgate et 
al. 1986).  Failure of the ventral migration of the P nuclei can result in laterally 
displaced VD neuron cell bodies.  This phenotype is observed in mig-2; ced-10 
double mutants, but not in unc-115 mutants (Lundquist, Reddien et al. 2001).  
Possibly, ectopic activity from MYR::UNC-115 impedes P nucleus migration.  
rack-1(tm2262) suppressed the displaced VD cell body defect of myr::unc-115 
(Figure 8A):  30% of myr::unc-115 animals  had misplaced VD cell bodies 
compared to 15% of rack-1(tm2262); myr::unc-115 (p = 0.011).  This result 
suggests that RACK-1 might act downstream of or participate with MYR::UNC-
115 in impeding P nucleus migration, again suggesting context-dependent 
interactions of UNC-115 and RACK-1. 
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rack-1(tm2262) caused gonadal distal tip cell migration defects.  The C. 
elegans gonad is derived from two somatic cells (Z1 and Z4) surrounding the two 
germ cells (Z2 and Z3) (Kimble and Hirsh 1979).  Z1 and Z4 divide to produce 
the somatic cells of the gonad.  Before morphogenesis, the gonad is oval shaped 
and located ventrally in the middle of the animal.  The distal tip cells (DTCs) at 
the anterior and posterior tips of the gonad begin migration, and as they migrate 
they lead the gonad behind them.  The DTCs migrate anteriorly and posteriorly, 
turn dorsally and migrate to the dorsal region of the animal, and then migrate 
posteriorly and anteriorly back toward the middle of the animal.  DTC migration 
results in the U-shaped bi-lobed gonad of C. elegans (Figure 10A).  If DTC 
migration is perturbed, misrouted and misshapen gonads result.  The gonads of 
32% of rack-1(tm2262) animals were misrouted (Figures 10B and C).  Misrouting 
defects included failure to turn dorsally as well as extra turns, such as turning 
back ventrally after the dorsal migration.  We did not observe gonads that had 
extended past their normal stopping point near the middle of the animal, as has 
been observed in other mutations that affect DTC migration (Tannoury, 
Rodriguez et al. ; Meighan and Schwarzbauer 2007).  A rack-1::gfp transgene 
rescued gonad misrouting defects in rack-1(tm2262) (32% to 5%; p < 0.005) 
(Figure 10C), indicating that the gonad defects were due to rack-1 perturbation.  
It should be noted that rack-1(tm2262) homozygotes from a heterozygous mother 
(rack-1(tm2262M+)) had less severe DTC migration defects compared to the 
rack-1(tm2262) animals without maternal contribution (21% compared to 32%; p 
= 0.03).  This indicates that DTC migration defects were partially rescued by wild-
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type maternal rack-1(+) activity.  unc-115 mutants displayed no defects in DTC 
migration, and the gonad defects of rack-1 were not affected by unc-115 (data 
not shown).  rack-1::myc also rescued the DTC migration defects of rack-
1(tm2262) (data not shown).  Thus, DTC migration is controlled by RACK-1 and 
is independent of UNC-115/abLIM. 
 CED-10/Rac and MIG-2/RhoG have previously been shown to control 
gonad distal tip cell migration (Lundquist, Reddien et al. 2001), and we have 
shown here that RACK-1 also controls DTC migration.  To determine if RACK-1 
interacts with Rac signaling in DTC migration, we analyzed DTC migration in 
double mutants. 
 As reported previously, both ced-10(n1993) and mig-2(mu28) mutations 
caused defects in DTC migration (27% for mig-2(mu28), 12% for ced-10(n1993)) 
(Figure 10C) (Lundquist, Reddien et al. 2001).  We found that double mutants of 
ced-10 and mig-2 with rack-1 showed no significant difference in defects 
compared to the stronger singles alone.  rack-1(tm2262M+); mig-2(mu28) 
showed no significant difference (26%) compared to mig-2(mu28) (27%), and 
rack-1(tm2262M+) ced-10(n1993) showed no significant difference compared to 
rack-1(tm2262M+) (21% in each case). 
 CED-10/Rac and MIG-2/RhoG interact differently in the DTCs than they 
do in other tissues such as axons, in which they act in parallel redundant 
pathways.  ced-10; mig-2 double mutants did not display enhanced DTC 
migration defects compared to either single alone (Lundquist, Reddien et al. 
2001), suggesting that they might act in the same pathway or in independent 
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pathways that each control a distinct aspect of DTC migration.  Our results 
suggest the same for RACK-1, that it might act in a pathway independent of 
CED-10 and MIG-2, or that CED-10, MIG-2 and RACK-1 might all act in the 
same pathway in DTC migration. 
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2.4 Discussion 
In summary, we have presented data indicating that RACK-1 is required cell 
autonomously for axon pathfinding, and that RACK-1 is required for migration of 
the distal tip cells of the gonad.  We show that RACK-1 interacts physically with 
UNC-115/abLIM, and that RACK-1 and UNC-115/abLIM might act in the same 
pathway in axon pathfinding.  Consistent with this idea, RACK-1 was required for 
ectopic lamellipodia and filopodia induced by the activated CED-10/Rac GTPase, 
similar to UNC-115/abLIM.  RACK-1-like molecules have been implicated in a 
wide variety of cellular events and have been shown to interact with a large 
number of distinct protein complexes, consistent with the idea of RACK 
molecules as scaffolds and integrators (Sklan, Podoly et al. 2006).  RACK 
molecules have been shown to control cell adhesion and migration and interact 
with Src, c-Abl, Rho GTPase regulators, and integrins in these events (Liliental 
and Chang 1998; Besson, Wilson et al. 2002; Kiely, Baillie et al. 2009).  Our 
studies here suggest that RACK-1 interacts with the actin-binding protein UNC-
115/abLIM and Rac GTPases in the control of axon pathfinding and cell 
migration. 
 Previous studies showed that in C. elegans, RACK-1 depletion by RNAi 
resulted in embryos with cytokinesis defects, including shorter astral 
microtubules, defects in chromosome separation, and defects in membrane 
organization and recycling endosome distribution (Ai, Poole et al. 2009).  We 
found that the deletion rack-1(tm2262) was very sick and slow-growing, and gave 
very few progeny.  rack-1(tm2262) produced very few embryos, suggesting that 
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the animals had defects in sperm and/or oocyte production. Indeed, rack-1 RNAi 
resulted in defects in germline membrane organization (Ai, Poole et al. 2009), 
consistent with the sterility that we observed in the rack-1(tm2262) mutant.  
 
RACK-1 is cell autonomously required for axon pathfinding.  rack-1(tm2262) 
mutants displayed a variety of axon pathfinding defects, including left-right choice 
and guidance defects of the VD and DD commissural motor axons and guidance 
defects of the PDE axons.  VD/DD axons are dorsally directed, and PDE axons 
are ventrally directed, indicating that rack-1 is not specific for any particular 
guidance direction.  VD/DD axon pathfinding defects were rescued when rack-
1(+) was expressed under a promoter that specifically drives expression in the 
GABAergic neurons including VD/DD and nowhere else, demonstrating that 
RACK-1 is required cell-autonomously for axon pathfinding.  As RACK-1 is likely 
involved in many different developmental events, this result shows that the 
effects of RACK-1 on axon pathfinding are due to defects in the neuron itself and 
not a substrate or guidepost tissue such as the hypodermis or other neurons.  
Indeed, RACK-1 was expressed in neurons, and functional RACK-1::GFP fusion 
protein accumulated in the growth cones of neurons, consistent with a role of 
RACK-1 in growth cone cytoskeletal regulation.  RACK-1::GFP also accumulated 
in the cell bodies and axons of neurons. 
 
RACK-1 controls distal tip cell migration.  We have shown that rack-
1(tm2262) mutants display defects in the structure of the gonad arms consistent 
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with a defect in distal tip cell migration.  rack-1 is expressed in the migrating 
distal tip cells.  The Rac GTPases CED-10/Rac and MIG-2/RhoG also each 
affect distal tip cell migration, but do not show the phenotypic synergy in DTC 
migration as is observed in axon pathfinding (Lundquist, Reddien et al. 2001).  
Thus, CED-10/Rac and MIG-2/RhoG might act in independent pathways that 
control distinct aspects of DTC migration. 
 DTC migration defects in mig-2; rack-1 and ced-10 rack-1 double mutants 
were not significantly different than the stronger single mutants alone.  This result 
suggests that RACK-1 might act in a pathway independent of MIG-2 and CED-
10, or that all three act in a comon pathway.  This again points to context 
dependent differences in the function of RACK-1 and suggests that RACK-1 
might interact with different effectors in different ways in different cells and 
cellular events.  Indeed, the effect of RACK-1 on DTC migration is likely to be 
independent of UNC-115/abLIM, as unc-115 mutants have no effect on DTC 
migration alone or in any double mutant combination analyzed so far, including 
ced-10 and mig-2. 
 
RACK-1 acts in the CED-10/Rac and UNC-115/abLIM pathway in axon 
pathfinding.  A model of RACK-1 interaction with CED-10/Rac and UNC-
115/abLIM is shown in Figure 10A.  Double mutant analysis showed that rack-
1(tm2262) synergized with mig-2/RhoG and unc-34/Enabled in PDE axon 
pathfinding, similar to unc-115/abLIM and ced-10/Rac.  rack-1(tm2262) did not 
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synergize with unc-115/abLIM or ced-10/Rac, consistent with the idea that they 
act in the same pathway in parallel to mig-2/RhoG and unc-34/Enabled. 
 Activated CED-10(G12V) drives the formation of ectopic lamellipodia and 
filopodia in PDE neurons, and unc-115 loss of function suppresses this effect 
(Struckhoff and Lundquist 2003).  We show here that rack-1(tm2262) also 
partially suppressed ectopic lamellipodia and filopodia caused by CED-
10(G12V), indicating that RACK-1 is required downstream of CED-10/Rac in 
lamellipodia and filopodia formation (Figure 10A).  This result suggests that 
RACK-1 might normally be required for lamellipodia and filopodia formation.  This 
is in contrast to the seven-WD repeat protein SWAN-1, which physically interacts 
with the UNC-115 LIM domains and with CED-10/Rac but which is normally 
required to inhibit CED-10/Rac signaling in lamellipodia and filopodia formation 
(Yang, Lu et al. 2006).  Thus, these two seven-WD repeat proteins SWAN-1 and 
RACK-1 might have opposite effect on CED-10/Rac signaling:  SWAN-1 inhibits 
it, and RACK-1 is required downstream of it to form lamellipodia and filopodia.  
That RACK-1 is required for lamellipodia and filopodia formation downstream of 
CED-10/Rac suggests that RACK-1 might be acting directly in cytoskeletal 
regulation.  It is also possible that RACK-1 exerts its effects downstream of Rac 
GTPases through transcriptional or translational control, but the fact that RACK-1 
interacts physically with the actin-binding protein UNC-115/abLIM supports the 
idea that RACK-1 directly controls cytoskeletal signaling. 
 RACK-1 physically interacts with UNC-115/abLIM and genetically acts in 
the same pathway in axon pathfinding.  UNC-115 can be activated constitutively 
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by the addition of an N-terminal myristylation sequence (Struckhoff and 
Lundquist 2003), which mediates the covalent attachment of a fatty acid myristyl 
residue to the protein and drives localization to membranes, including the plasma 
membrane.  MYR::UNC-115 also drives the formation of ectopic lamellipodia and 
filopodia, similar to but weaker than CED-10(G12V) (Struckhoff and Lundquist 
2003).  No strong suppression or enhancement of axon pathfinding defects were 
observed in double mutants of rack-1(tm2262) and myr::unc-115.  One 
interpretation of these data is that RACK-1 does not act downstream of UNC-
115/abLIM and instead might act together with or upstream of UNC-115/abLIM.  
Indeed, unc-115 mutations suppressed the ectopic lamellipodia caused by 
MYR::RACK-1, indicating that UNC-115 acts downstream of RACK-1.  These 
results are consistent with a model in which RACK-1 acts downstream of CED-
10/Rac and upstream of UNC-115/abLIM in axon pathfinding (Figure 11). 
  
RACK-1 and MYR::UNC-115 display context-specific interactions.  RACK-1 
and UNC-115 displayed context-dependent interactions in addition to those 
described in the PDE neurons above.  First, rack-1 slightly but significantly 
increased VD/DD commissural pathfinding defects caused by myr::unc-115.  We 
do not understand the nature of the VD/DD axon pathfinding defects caused by 
MYR::UNC-115, but it is possible that they are due to excessive lamellipodial and 
filopodial protrusion, possibly in the growth cone.  If this is the case, these effects 
were enhanced by rack-1 loss of function, suggesting that RACK-1 might 
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negatively regulate MYR::UNC-115 in this context, possibly by excluding 
MYR::UNC-115 from regions in which it induces lamellipodia and filopodia. 
 Second, rack-1(tm2262) suppressed the lateral displacement of VD cell 
bodies caused by myr::unc-115.  Laterally misplaced VD cell bodies are 
indicative of a defect in the ventral migration of the nuclei of the P cells.  UNC-
115 is not normally involved in P nucleus migration, but ced-10/Rac and mig-
2/RhoG act redundantly in the process (Lundquist, Reddien et al. 2001).  
Possibly, myr::unc-15 ectopically interferes with P nucleus migration, and RACK-
1 is required for this effect.  In this case RACK-1 might normally positively 
regulate MYR::UNC-115.  In any case, these data indicate that RACK-1 and 
UNC-115 might have distinct interactions in different cellular contexts. 
 In summary, these studies suggest that RACK-1 acts in a common 
pathway with CED-10/Rac and UNC-115/abLIM in axon pathfinding (Figure 11).  
These studies implicate the Receptor of Activated C Kinase as a new Rac 
GTPase effector molecule, as RACK-1 acts downstream of CED-10 and 
upstream of UNC-115/abLIM in axon pathfinding.  Future studies will be directed 
at understanding the roles of plasma membrane localization and phosphorylation 
in the regulation of this pathway. 
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2.5. Materials and Methods 
C. elegans genetics and culture: C. elegans culture and techniques were 
performed using standard protocols (Brenner 1974; Sulston and Hodgkin 1988).  
All experiments were performed at 20oC.  The rack-1(tm2262) allele was 
provided to us by the National Bioresource Project for the Experimental Animal 
“Nematode C. elegans” (S. Mitani), and was outcrossed to wild-type N2 animals 
three times before analysis.  Polymerase chain reaction (PCR) was used to verify 
the homozygosity of rack-1(tm2262) in strains.  The following mutations and 
genetic constructs were used:  LGII:  juIs76[unc-25::gfp]; LGIV: ced-10(n1993), 
rack-1(tm2262), nT1 IV:V, lqIs3[osm-6::gfp]; LGV:  unc-34(e951); LGX:  unc-
115(ky275), mig-2(mu28), lqIs2[osm-6::gfp]; LG?:  lqIs62[myr::unc-115(+)].  C. 
elegans transformation was performed by standard techniques using DNA 
microinjection into the syncytial germline of hermaphrodites (Epstein and Shakes 
1995).  Transgenes were integrated into the genome using trimethylpsoralen and 
standard techniques (Mello, Kramer et al. 1991; Anderson 1995). 
 All micrographs were obtained on a Leica DMRE microscope with a 
Qimaging Rolera MGi EMCCD camera or a Qimaging Retiga CCD camera.  
Openlab and IPlab software were used to obtain images. 
 
Molecular biology:  All coding regions amplified by PCR were sequenced to 
ensure the absence of mutations in the sequence.  PCR, recombinant DNA and 
other molecular biology techniques were performed according to standard 
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techniques (Sambrook 1989).  Primer and plasmid sequences are available upon 
request. 
 
Scoring of VD, DD and PDE axon defects:  Axon pathfinding defects were 
scored with fluorescence microscopy of hermaphrodite animals in the fourth 
larval stage (L4) or young adults expressing a green fluorescent protein 
transgene for specific cells. To visualize and score the axons of VDs and DDs, 
animals harboring an unc-25 promoter::gfp integrated transgene (juIs76 II) were 
used (Jin, Jorgensen et al. 1999).  To visualize and score PDE axons, animals 
harboring an osm-6 promoter::gfp integrated transgene (lqIs2 X or lqIs3 IV) were 
used (Collet, Spike et al. 1998; Struckhoff and Lundquist 2003).  VD/DD Lateral 
asymmetry:  VD/DD commissural axons normally extend up the right side of the 
animal (except the VD1/DD2 commissure, which extends on the left).  The 
number of animals with aberrant left-side extension of commissural axons was 
scored.  VD/DD axon pathfinding:  A VD/DD commissural axon that failed to 
reach the dorsal nerve cord or that wandered laterally before reaching the dorsal 
nerve cord was considered mutant.  The percent of animals with pathfinding 
defects was noted, and the percentage of defective axons was noted.  VD cell 
body displacement:  The VD neurons are descendants o the P cells.  If the P 
nuclei fail to migrate ventrally, the resulting VD cell bodies can be laterally 
displaced out of the ventral nerve cord.  The percentage of animals with laterally 
displaced VD cell bodies was scored.   PDE axon pathfinding:  The cell bodies of 
the PDE neurons (PDEL and PDER) are situated in the posterior lateral post-
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deirid ganglion.  PDEs extend an axon ventrally to the ventral nerve cord, which 
then bifurcates and extends anteriorly and posteriorly in the ventral nerve cord.  If 
the axon failed to reach the ventral nerve cord or wandered beyond a 45o angle 
from a straight line ventrally from the cell body, it was considered mutant.  
Significance was determined using Fisher Exact Analysis. 
 
Activated ced-10(G12V), mig-2(G16V), and myr::unc-115 transgenes.  ced-
10(G12V) and mig-2(G16V) transgenes under the control of the osm-6 promoter 
were used as described previously (Struckhoff and Lundquist 2003).  A myr::unc-
115 transgene under the control of the unc-115 promoter was used as described 
previously (Yang and Lundquist 2005). 
 
Scoring of distal tip cell migration defects: Gonadal distal tip cell migration 
defects were scored by Differential Interference Microscopy in young adult 
hermaphrodite animals.  Any deviation from the normal U-shape of gonad arms 
was scored as defective, including failure to migrate fully, failure to make a dorsal 
turn, failure to make an anterior or posterior turn, or extra dorsal-ventral or 
anterior-posterior turns.  Significances of differences (p values) were determined 
using Fisher Exact Analysis. 
 
RACK-1 transgenes.  A full-length rack-1(+) transgene was generated by PCR 
from genomic DNA (based on the Wormbase gene model K07D7.1) and included 
the entire upstream rack-1 region (~2.5 kb), the coding region, and the 
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downstream region past the poly-A addition site (Figure 1E).  rack-1::gfp and 
rack-1::myc  fusion constructs were generated by amplifying the entire rack-1 
upstream region and coding region lacking the stop codon fused in frame to gfp 
or myc.  The unc-25 promoter::rack-1::gfp fusion protein was generated by 
amplifying the rack-1 coding region lacking the upstream region. This fragment 
was placed downstream of the unc-25 promoter and fused in frame to gfp at the 
3’ end. 
 
UNC-115 yeast-two-hybrid screen:  The two-hybrid screen was conducted at 
the Molecular Interaction Facility at the University of Wisconsin-Madison (thanks 
to E. Maher).  In a liquid multi-well format, approximately 36 million C. elegans 
cDNA clones representing both oligo dT and random-primed libraries were 
screened via mating.  UNC-115 was fused to the GAL4 DNA-binding domain in 
the pBUTE plasmid and the prey cDNAs were fused to the GAL4 activation 
domain in the pACT plasmid.  In the yeast strain, the bacterial lacZ gene and the 
HIS5 gene were under the control of a GAL4-regulated promoter.  The interaction 
screen consisted of assaying β-galactosidase (β-gal) activity (for lacZ) and 
growth on 25mM 3-aminotriazole (3-AT) (for HIS5).  This analysis identified 244 
potential interacting cDNAs that had β-gal activity and grew on 25mM 3-AT.  
From these 244, 142 isolates activated both lacZ and HIS5 similarly when re-
tested.  Of these, 124 were bait-specific and did not activate when the bait 
plasmid was removed.  These cDNAs were sequenced, and seven of these were 
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found to represent the K07D7.1 gene in Wormbase (rack-1) (Ai, Poole et al. 
2009). 
 
RACK-1::MYC Immunoprecipitation.  In order to obtain large amounts of C. 
elegans protein extract, animals carrying an integrated rack-1::myc transgene 
were raised at room temperature in a liquid culture containing 2.5mg cholesterol, 
0.05mg/mL streptomycin, Escherichia coli strain HB101 and M9 buffer (up to 
500mL).  After about a week, these animals were harvested and snap-frozen in 
liquid nitrogen. We then added lysis buffer (1X PBS, 10% glycerol, 0.1% NP40, 
0.1% Tween) in a 1:1 ratio, and then 1mM of phenylmethanesulphonylfluoride. 
We lysed the animals with glass beads in a beater for two cycles of 1 minute 
each. The supernatant was then collected and stored at –80oC for further 
experiments. We based our immunoprecipitation assays in Clonetech 
Laboratories’ protocol No. PT3407-1 (Clonetech).  We performed the standard 
immunoprecipitation assays as described in (Yang, Lu et al. 2006) using protein 
G (Zymed) and anti-Myc monoclonal antibody (Clontech).  The anti-UNC-115 
antibody is described in (Yang, Lu et al. 2006). 
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Figure 2.1 
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Figure 2.1.  RACK-1 and UNC-115 interact by two-hybrid and co-
immunoprecipitation.  A)  A schematic diagram of the 639-residue UNC-115 
molecule.  LIM = LIM domains; VHD = villin headpiece domain; UAD = unc-
115/abLIM/dematin domain.  The bar represents the region of the molecule used 
as bait in a two-hybrid screen.  B)  UNC-115 co-immunoprecipitated with MYC-
tagged RACK-1.  Lysates of worms expressing MYC-tagged RACK-1 were used 
in immunoprecipitation experiments with and without anti-Myc antibody.  Western 
blots using anti-UNC-115 antibody (Yang, Lu et al. 2006) (top) showed that UNC-
115 co-immunoprecipitated with RACK-1::MYC.  Western blots using anti-Myc 
showed that RACK-1::MYC was expressed (input) and was immunoprecipitated.  
RACK-1::MYC ran just below the Ig heavy chain of the anti-Myc antibody used in 
the immunoprecipitation.  C)  The rack-1 gene and tm2262 allele.  This model is 
based on the K07D7.1 gene model in Wormbase and on the cDNAs sequenced 
from the two-hybrid screen.  tm2262 is a 331-bp deletion.  (D) Schematic 
diagram of the 325-residue RACK-1 protein.  WD = WD repeat; PKC = 
conserved protein kinase C interaction sites; Y = conserved tyrosine 
phosphorylated by Src in mammalian RACK.  The region removed by the tm2262 
deletion is indicated.  D)  Sequence of the rack-1 cDNA and protein.  cDNA 
sequence:  The sequence of the RACK-1 cDNA is based upon sequencing seven 
cDNAs isolated from the two-hybrid screen and on cDNA sequences in 
Wormbase.  The predicted open reading frame is upper case, and the 5’ and 3’ 
untranslated regions are lower case.  A predicted poly-A addition site is 
underlined, and poly A residues are present in the cDNAs at the end of the 
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sequence shown here.  The nucleotides removed by the tm2262 deletion are 
shaded in grey.  The starting points of the five independent cDNAs isolated in the 
two-hybrid screen are highlighted in black.  Amino acid sequence:  The predicted 
amino acid sequence is shown below the cDNA sequence.  The WD repeats are 
underlined; the two conserved PKC interaction sites are highlighted in black; and 
the conserved tyrosine residue that is phosphorylated by Src in mammalian 
RACK is highlighted in black. 
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Figure 2.2 
 
 
 
 
 
 
 
 
rack-1(RNAi) wild-type 
A B 
F 
rack-1(tm2262) 
E 
wild-type 
rack-1(tm2262) wild-type 
D 
D 
V 
V 
D C 
 51 
Figure 2.2. RACK-1 is required for VD/DD motor axon pathfinding.  All 
panels are micrographs of animals with unc-25promoter::gfp expression (juIs76 
transgene) in the VD/DD GABAergic motor neurons.  The scale bar in A 
represents 10µm for all panels.  (A and B) Wild-type and rack-1(RNAi) showing 
the DD1/VD2 commissure on the left side of the animal.  Misrouted and branched 
axons are indicated by an arrow.  Dorsal is up, and anterior is left.  (C and D) 
Dorsal views of the dorsal nerve cords (marked by a D) of wild-type and rack-
1(tm2262).  This dorsal view allows for demonstration of the sidedness of axon 
pathfinding.  The cell bodies in the ventral nerve cord are out of focus (marked by 
a V).  The arrow in C points to the DD1/VD2 commissure on the left side of the 
animal.  All other VD/DD commissures go up the right side.  Arrows in D point to 
VD/DD commissures that aberrantly extend up the left side of the animal in rack-
1(tm2262).  (E and F) VD/DD commissures in wild-type and rack-1(tm2262).  The 
arrow in F points to a misguided axon. 
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Figure 2.3 
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Figure 2.3.  RACK-1 acts cell autonomously in VD/DD motor axon 
pathfinding.  The Y axis denotes genotype, and the X axis represents 
percentage of defects of the sort described in the legend.  Ex[rack-1(+)] is the 
full-length rack-1::myc transgene under the rack-1 endogenous promoter, and 
Ex[unc-25::rack-1(+)] is a transgene with rack-1::gfp expression driven by the 
unc-25 promoter specifically in the GABAergic neurons, including the VD/DDs.  
VD/DD commissural axon pathfinding defects were scored by animal (the 
percent of animals with defective axons) or by axon (the percent of defect 
axons).  Number of animals or axons scored is indicated in the bars.  P-values 
for significance were determined by Fisher Exact Analysis. 
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Figure 2.4 
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Figure 2.4.  RACK-1 is expressed in most cells, including neurons and the 
gonadal distal tip cells.  Panels are fluorescent micrographs of animals 
harboring rack-1::gfp transgenes.  (A and B) are fusions of the rack-1 promoter to 
gfp; and (C and D) are fusions of the entire full-length rack-1 coding region to 
GFP.  A) A distal tip cell expressed rack-1::gfp.  B) Neurons expressed rack-
1::gfp.  C) Full-length RACK-1::GFP was expressed in neurons in the ventral 
nerve cord (arrows) and in the amphid (arrowhead).  D) Full-length RACK-1::GFP 
was excluded from nuclei in tail hypodermis and gut (arrows).  The scale bar in A 
represents 5µm for A-C, and the scale bar in D represents 5µm. 
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Figure 2.5 
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Figure 2.5.  RACK-1::GFP expression in GABAergic motor neurons.  
Micrographs are of animals harboring an unc-25::rack-1::gfp transgene that 
expresses a full-length RACK-1::GFP fusion protein specifically in the VD/DD 
GABAergic motor neurons.  A) RACK-1::GFP expression is specific to the VD/DD 
motor neurons.  Arrowheads indicate cell bodies in the ventral nerve cord, and 
arrows indicate commissural axons.  The punctate fluorescence throughout the 
animal is autofluorescence of the gut.  B) RACK-1::GFP accumulated in a VD 
growth cone in an early L2 animal (arrow).  The diagram at the right traces the 
outline of the growth cone and axon.  The scale bars represent 5µm. 
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Figure 2.6 
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Figure 2.6.  RACK-1 acts genetically in the CED-10/Rac and UNC-115/abLIM 
pathway.  (A and B) Micrographs of animals with osm-6::gfp expression in the 
PDE neurons.  The arrow in A indicates a wild-type axon, and the arrow in B 
indicates a misguided axon in a mig-2(mu28) mutant.  The scale bar represents 
5µm for A and B.  C) The graph represents percent of PDE axon pathfinding 
defects in different genotypes.  At least 100 neurons were scored for each 
genotype, and p-value significance was determined by Fisher Exact Analysis.  
The genotypes indicated with an NS are not significantly different in any pairwise 
combination. 
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Figure 2.7 
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Figure 2.7.  rack-1(tm2262) partially suppresses activated CED-10(G12V), 
but not MIG-2(G16V) or activated MYR::UNC-115.  A) A micrograph of the 
PDE neuron of an adult animal expressing activated CED-10(G12V).  An ectopic 
lamellipodial protrusion is indicated by an arrow.  The scale bar represents 5µm.  
B) Quantitation of PDE defects.  lqIs14 is the osm-6::ced-10(G12V) transgene; 
lqIs46 is the osm-6::mig-2(G16V) transgene; and lqIs62 is the unc-115::myr::unc-
115 transgene.  At least 100 neurons were scored for each genotype, and p-
value significance was determined by Fisher Exact Analysis. 
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Figure 2.8 
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Figure 2.8.  Activated MYR::UNC-115 in VD/DD motor neurons is not 
suppressed by rack-1(tm2262).  A) Quantitation of VD/DD defects caused by 
expression of MYR::UNC-115 from the unc-115 promoter, which is expressed in 
the VD/DD neurons.  The asterisks represent a test of additivity of the 
represented genotypes.  The double mutant is significantly different from each 
single, and the double mutant had defects that were significantly stronger than 
the additive effects of each single.  The following formula was used to predict the 
additive effect of the double mutant based on the single mutant phenotypes:  
rack-1(tm2262) + lqIs62 – (rack-1(tm2262) * lqIs62); or 0.42 + 0.21 – (0.42 * 
0.21) = 0.54.  At least 100 animals were scored, and p-value significance was 
determined by Fisher Exact Analysis.  B)  A VD neuron cell body was laterally 
displaced (arrow) in a rack-1(tm2262M+); lqIs62[myr::unc-115] animal.  rack-
1(tm2262) partially suppressed this phenotype compared to lqIs62 alone.  
Arrowheads indicate VD/DD cell bodies in their normal positions in the ventral 
nerve cord. 
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Figure 2.9 
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Figure 2.9.  UNC-115 is required for the effects of MYR::RACK-1.  A)  A 
micrograph of MYR::RACK-1::GFP expression in the PDE neuron driven by the 
osm-6 promoter.  The arrowhead points to the cell surface accumulation of 
MYR::RACK-1::GFP, and the arrow points to an ectopic lamellipodium.  The 
scale bar represents 5 µm.  B)  Quantitation of ectopic lamellipodial defects in 
PDEs expressing MYR::RACK-1::GFP. At least 100 animals were scored for 
each genotype, and p-value significance was determined by Fisher Exact 
Analysis. 
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Figure 2.10 
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Figure 2.10.  RACK-1 is required for gonadal distal tip cell migration.  (A and 
B) Differential Interference Contrast micrographs of wild-type and rack-1(tm2262) 
gonads.  Dashed lines trace the outline of the gonad arm.  The scale bar in A 
represents 10µm.  C) Quantitation of gonad arm migration defects.  Number of 
gonad arms scored is indicated in the bars (>100).  P-value significance was 
determined by Fisher Exact Analysis.  The predicted additive effect of the rack-
1(tm2262M+) ced-10(n1993M+) double if they did not interact was calculated by 
the formula rack-1(tm2262) + ced-10(n1993) – (rack-1(tm2262) * ced-10(n1993); 
or 0.32 + 0.14 – (0.32 * 0.14) = 0.42.  This number was also significantly different 
that the observed rack-1(tm2262M+) ced-10(n1993M+) double mutant. 
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Figure 2.11 
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Figure 2.11. RACK-1 might regulate UNC-115/abLIM downstream of CED-
10/Rac in lamellipodia and filopodia formation.  A linear pathway representing 
the genetic interactions between ced-10/Rac, rack-1, and unc-115.  RACK-1 acts 
downstream of CED-10/Rac and controls UNC-115/abLIM.  LIM = LIM domain; 
VHD = villin headpiece domain.  
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Chapter III 
The actin-binding protein UNC-115/abLIM interacts with the protein kinase 
C orthologs PKC-1 and TPA-1, and with the Nck-Interacting Kinase MIG-
15/NIK, via the receptor for activated C kinase 1 (RACK-1) during  C. 
elegans axon pathfinding 
 
 
 
 
 
 
 
 
 
 
 
 
 
 71 
3.1. Abstract 
 Three of the main pathways involved in the reshaping of the peripheral 
actin cytoskeleton to promote cell migration and axon guidance are the Rac 
GTPases, PKCs and Src kinases. In C. elegans axon pathfinding, the actin-
binding protein UNC-115/abLIM acts with the Rac pathway. UNC-115/abLIM is 
believed to be activated in a step-wise manner: when at the leading edge of the 
growth cone, the Rac GTPase CED-10 signals to the scaffolding protein RACK-1 
to recruit UNC-115/abLIM. UNC-115/abLIM can possibly be modulated via 
phosphorylation of its villin headpiece domain. Because RACK-1 is a scaffolding 
protein that does not have any catalytic domains on itself, but has putative sites 
of interaction with other molecules such as PKC and Src, we wondered if these 
kinases could be acting with UNC-115/abLIM and RACK-1 downstream of Rac 
GTPases in axon pathfinding. 
 Our data reveal a novel interaction between PKC and UNC-115/abLIM via 
RACK-1, possibly integrating the PKC and Rac GTPase signaling pathways. We 
also show that the Nck-interacting Kinase MIG-15 is another putative modulator 
of the activity of UNC-115 in this process. 
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3.2. Introduction 
During the long journey on which an axon goes to find its proper path, 
complex extra- and intra-cellular mechanisms act in the receiving, processing 
and modulation of the guidance signals presented to the growth cone (Chan, 
Zheng et al. 1996; Hao, Yu et al. 2001; Adler, Fetter et al. 2006; Quinn, Pfeil et 
al. 2008). As described in the previous chapter, one set of molecules that 
regulates intra-cellularly filopodia and lamellipodia morphology and dynamics 
during growth cone migration is the Rac GTPases. MIG-2/RhoG and CED-
10/Rac, the two redundant Caenorhabditis elegans Rac GTPases, act in parallel 
to control the actin nucleator Arp2/3 complex (Shakir, Jiang et al. 2008). The 
Arp2/3 complex has been involved in many aspects of cell and growth cone 
migration, including the modulation of filopodial and lamellipodial protrusions  
(Borisy and Svitkina 2000; Pollard and Borisy 2003). MIG-2/RhoG acts in a 
pathway that activates the GEX-2/Sra-1, GEX-3/Kette and WSP-1/Wasp 
complex, while CED-10/Rac acts in the GEX-2/Sra-1, GEX-3/Kette and WVE-
1/Wave activation pathway. Both WSP-1/Wasp and WVE-1/Wave pathways yield 
in the Arp2/3 complex activation (Shakir, Jiang et al. 2008). 
While much is known about the pathways that lead to the activation of the 
Arp2/3 complex, less is known about the activation of other actin-binding proteins 
that also contribute to growth cone dynamics. The actin-binding UNC-115/abLIM 
acts downstream of CED-10/Rac in axon pathfinding (Struckhoff and Lundquist 
2003). In vivo growth cone studies have shown that, like the Arp2/3 complex, 
UNC-115/abLIM has a role in filopodia and lamellipodia dynamics as well (Norris, 
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Dyer et al. 2009). UNC-115/abLIM has a C-terminal villin headpiece domain 
(VHD) that binds to f-actin, and three N-terminal LIM domains that physically 
interact with the negative Rac regulator SWAN-1 (Yang, Lu et al. 2006). A 
conserved region of unknown function in the middle of the protein was found to 
interact with the Receptor for Activated C Kinase (RACK-1), a molecule that also 
works downstream of CED-10/Rac (Demarco and Lundquist 2010). Epistasis 
analyses revealed that the activation of UNC-115/abLIM seems to be in a step-
wise manner: once activated at the plasma membrane, CED-10/Rac recruits 
RACK-1, which in turn will recruit UNC-115/abLIM for its actin modulatory activity 
(Figure 3.1). Because RACK-1 is a seven-WD repeat scaffolding protein, the 
UNC-115=RACK-1 interaction is hypothesized to be required for the proper 
spatial regulation of UNC-115/abLIM. Both UNC-115/abLIM and RACK-1 have 
putative phosphorylation sites that could be regulatory targets for kinases and 
phosphatases in the appropriate control of axon pathfinding. 
In addition, Rack1-like molecules have been suggested to interact with 
many different proteins involved in cell migration and adhesion, including 
Integrins, Src, Protein Kinase C (PKC) and Rho GTPase regulators (Chang, 
Conroy et al. 1998; Liliental and Chang 1998; Buensuceso, Woodside et al. 
2001; Sklan, Podoly et al. 2006). In fact, mammalian Rack1 was first identified as 
the intracellular receptor of PKC (Ron, Chen et al. 1994; Schechtman and 
Mochly-Rosen 2001). Because C. elegans RACK-1 has two conserved predicted 
PKC-binding sites, and is also a predicted substrate for Src phosphorylation, 
these two classes of molecules seemed like good candidates for putative 
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regulators of UNC-115/abLIM. PKCs are master regulators of the cell machinery, 
and have been implicated in many aspects of cell migration and neuronal 
development (Kikkawa, Kitano et al. 1986; Besson, Wilson et al. 2002; Wolf, 
Lyuksyutova et al. 2008). Like UNC-115/abLIM, PKC activity is required for 
growth cone behavior and filopodia modulation (Cheng, Mao et al. 2000). One 
PKC effector , the myristoylated, alanine rich C-kinase substrate (MARKS), has a 
role in growth cone pathfinding (Gatlin, Estrada-Bernal et al. 2006). C. elegans 
has four PKC ortholog genes, and they are all putatively expressed in the 
nervous system (Tabuse 2002). The tpa-1 gene encodes two orthologs of the 
novel PKCs (nPKC) δ and θ, the only phorbol-ester induced PKC isoforms in the 
nematode (hence its particular name, tetradecanoyl phorbol acetate resistant). 
The pkc-1 gene encodes two isoforms, PKC-1A and B, which are neuron-specific 
and highly homologous to the mammalian nPKCε. PKC-1 displays Ca2+-
independent kinase activity, which is typical of nPKCs. The pkc-2 gene encodes 
six predicted PKC isoforms, mostly related to the conventional PKCα and 
β (cPKC). cPKCs require diacylglycerol (DAG), Ca2+ and a phospholipid for their 
activation. Finally, the pkc-3 gene encodes an atypical PKC (aPKC) isoform that 
is most similar to mammalian aPKCζ and λ/ι. PKC-3 is involved in establishing 
the early embryo polarity and interacts with the PAR complex and CDC-42, and 
has Ca2+- and DAG/phorbol ester-independent kinase activity. Depictions of the 
longest PKC isoforms from each gene product can be seen in Figure 3.2. 
Besides pkc-3, all other pkc genes encode multiple isoforms with differential 
regulatory elements and/or expression patterns. Therefore, a multitude of 
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functions could be performed by products from each pkc gene depending on how 
and when they are being expressed. 
 Srcs are non-receptor tyrosine kinases that, like the PKCs, also control 
many aspects of cell biology, including axon pathfinding and growth cone 
morphology (Li, Lee et al. 2004; Robles, Woo et al. 2005; Li, Aurandt et al. 2006). 
C. elegans has two SRC-like proteins (Figure 3.2). SRC-1 has been reported to 
be expressed in the nervous system, and to work with Wnts for endodermal cell 
fate specification and the Netrin receptor UNC-5 for cell and growth cone 
migration independently of Rac GTPases (Bei, Hogan et al. 2002; Itoh, Hirose et 
al. 2005). Though not as much is known about the function of SRC-2, in a yeast-
expression system, SRC-2 overexpression caused an overall increase of tyrosine 
phosphorylation. In this same system, SRC-2 is suppressed by CSK-1, a 
predicted negative-regulator of Src activity (Bizat, Peyrin et al. 2010). 
Not surprisingly, interactions between the Rho GTPase, Src and PKC 
signaling pathways have been reported in diverse systems, including the cell 
extension of vascular smooth muscle and ruffling of MDCK cell plasmalemma 
(Chianale, Rainero et al. ; Brandt, Gimona et al. 2002). Not all cross-talk between 
these systems is positive though. Interestingly, after PKC activation, Rack1 
inhibits Src signaling in cell migration (Chang, Harte et al. 2002). That we 
identified RACK-1 as a modulator of UNC-115/abLIM, a downstream component 
of the CED-10/Rac pathway, suggests we might have uncovered a site of action 
where PKCs and Srcs cross-talk with Rac GTPases for the proper control of 
growth cone migration. 
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Another kinase that could putatively control the activity of UNC-115/abLIM 
via RACK-1 is the serine-threonine NIK kinase MIG-15. Like the components of 
the CED-10/Rac pathway, mutations in mig-15 disrupt wild-type axon pathfinding 
(Shakir, Gill et al. 2006). C. elegans MIG-15 is the counterpart of the mammalian 
Nck-interacting kinase (NIK) and the Drosophila Misshapen proteins. N-
terminally, MIG-15/NIK has a STE20-like serine/threonine kinase domain 
followed by a proline-rich domain (PRD), while C-terminally it has a putative Rho 
regulatory CNH domain (Figure 3.2). Besides the genetic evidence linking MIG-
15/NIK to Rac GTPases in C. elegans, a yeast-two-hybrid screen suggested 
MIG-15/NIK putatively interacts with RACK-1 (Zhong and Sternberg 2006). 
Therefore, we also wondered if MIG-15 would be part of the activation complex 
needed to modulate UNC-115/abLIM. 
Here we present evidence that the two novel PKCs TPA-1 and PKC-1, and 
possibly MIG-15/NIK, interact with RACK-1 and UNC-115/abLIM during axon 
pathfinding. 
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3.3 Results 
A genetic strategy to screen possible genes that interact with rack-1 and 
unc-115. In PDE axon pathfinding, CED-10/Rac1 works in parallel to MIG-
2/RhoG to solely activate the RACK-1=UNC-115 pathway (Struckhoff and 
Lundquist 2003). Using the principles of genetic redundancy, in which mutations 
in genes that act in one pathway synergize with mutations in genes that act in a 
redundant, parallel pathway, we devised a hypothesis for the screen of candidate 
genes that could interact with rack-1 and unc-115/abLIM. If a gene acts with unc-
115/abLIM via rack-1, loss-of-function mutations in it should not worsen the 
defects of loss-of-function alleles of ced-10/Rac, rack-1, unc-115/abLIM, or the 
gene itself (if it happens to have a higher defect incidence than the established 
unc-115 pathway). At the same time, this mutant allele should synergize with 
mig-2/RhoG. However, if a gene acts in both pathways, in a third parallel 
pathway, or in a hierarchical level different than the rack-1=unc-115 level, then 
loss-of-function mutations in it should not follow these predictions. 
 
PKC-1/nPKC acts in the CED-10/Rac=RACK-1=UNC-115/abLIM pathway. We 
generated double-mutant combinations of all four pkc genes with the genes listed 
above. ok563 is a 310bp insertion and 1637bp deletion loss-of-function allele that 
removes the two first and part of the third exons of both pkc-1 isoforms. ok328 is 
a 7bp insertion and 2310bp deletion that removes part of nine exons of all pkc-2 
isoforms. ok544 is a G insertion and a 1551bp deletion that removes the four last 
exons of the pkc-3 gene. k501 is a C to T point mutation that affects both 
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isoforms of the tpa-1 gene and that causes a missense mutation in the protein 
(Pro-544-Ser, position based on the B0545.1a cDNA). Finally, k530 is a Tc1 
transposon insertion that also disrupts the function of TPA-1 (wild-type animals 
are sensitive to PMA, while both k501 and k530 mutant animals are resistant to 
the effects of TPA-1 overactivation with PMA). All chosen alleles are putative null 
alleles for the corresponding pkc genes. 
In PDE axon pathfinding, loss-of-function mutations in the genes coding 
for Rac GTPases and the actin-modulators RACK-1 and UNC-115/abLIM do not 
have a significant high incidence compared to wild type (Figure 3.3A). In ced-
10(n1993), 0% of animals display mutant PDEs. In mig-2(mu28), only 1% 
displayed mutant PDEs. In rack-1(tm2262) and unc-115(ky275), 1% and 4% of 
animals displayed non-wild type PDEs, respectively. 
pkc-1(ok563) animals displayed a mere 2% penetrance of PDE axon 
pathfinding defects. However, in a double mutant combination with mig-2(mu28), 
pkc-1(ok563) synergized the axon pathfinding defects observed (13% - 
p<0.003)). At the same time, pkc-1(ok563) did not significantly increase the 
defects seen in the other mutant combinations (with ced-10(n1993), 9% 
(p<0.025); with rack-1(tm2262), 8% (p<0.05); with unc-115(ky275), 3% (p<0.72)) 
(Figure 3.3C). 
 
PKC-1 acts cell-autonomously downstream of CED-10/Rac, RACK-1 and 
possibly UNC-115/abLIM in PDE neurons. Because the results above were 
consistent with pkc-1 working in the ced-10=rack-1=unc-115 pathway, we wanted 
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to investigate when during the activation process of UNC-115 would PKC-1 be 
required. The GTPase CED-10 can be constitutively activated by the introduction 
of a point mutation (Gly-12-Val) in the GTPase binding pocket of the protein. 
Such mutation favors the GTP-bound state of the GTPase, constitutively 
activating it. When expressed in the PDE neurons, this construct causes ectopic 
lamellipodia to emanate from the neurons (Figure 3.4B). UNC-115/abLIM and 
RACK-1 are thought to be active when recruited to the plasma membrane, 
possibly regulating the actin cytoskeleton in the growth cone during axon 
extension. When an N-terminal myristoylation sequence is added to these 
proteins, the resulting covalently-bound myristyl group inserts itself into the 
plasma membrane. Such membrane localization has been shown to result in 
ectopic lamellipodia resulting from a putative overactivation of these proteins. We 
asked if the loss of pkc-1 activity would suppress the overactivation phenotype 
resulting from the introduction of of these three constructs. 
In animals harboring a ced-10(G12V) construct expressed in PDE 
neurons, 91% of their neurons showed an ectopic lamellipodia. In a pkc-1(ok563) 
background, this number dropped to 67% (p<0.001), suggesting PKC-1 is 
needed for the activity of CED-10(G12V) during ectopic lamellipodia formation. 
When specifically expressing myr::rack-1, 15% of the PDE neurons analyzed 
displayed ectopic lamellipodia. Consistent with the idea that PKC-1 is needed 
downstream of its receptor for its activity, pkc-1(ok563);myr::rack-1 animals 
displayed only 4% of ectopic lamellipodial projections (p<0.008). Finally, when 
expressed specifically in the PDE neurons, myr::unc-115 displayed a 5% 
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penetrance of ectopic lamellipodia. In a pkc-1(ok563) background, only 1% of 
PDEs displayed such phenotype (p<0.001) (Figure 3.4A). Therefore, we 
concluded that PKC-1 is genetically required downstream of CED-10/Rac, 
RACK-1 and UNC-115/abLIM for their overactivation, and that it most-likely acts 
cell-autonomously in this process, since all overactive constructs that were 
suppressed by pkc-1(ok563) were expressed by the PDE promoter osm-6p. It is 
possible that PKC-1 is acting at the same level as UNC-115/abLIM, since 
MYR::UNC-115 only displayed a small percentage of lamellipodial protrusions to 
start with (i.e., the suppression from 5% to 1% could not be so significant) and 
UNC-115/abLIM is a possible direct or indirect target of PKC-1 (PKC-1 could be 
either phosphorylating UNC-115/abLIM directly, or regulating the activity of 
another kinase that would, in turn, phosphorylate UNC-115/abLIM). Future 
studies will address that hypothesis, by creating an overactive form of PKC-1 and 
addressing if the loss of unc-115 would suppress its overactivation. 
 
TPA-1/nPKC also acts with CED-10/Rac=RACK-1=UNC-115/abLIM in PDE 
axon pathfinding. Both tpa-1 loss-of-function alleles k501 and k530 displayed 
similar levels of defects on their own (1% and 0%, respectively). With mig-
2(mu28), k501 increased the defects observed to 13%, and k530 to 9% (both p 
values<0.001). Because k530 is a Tc1 insertion (such transposons have been 
reported to often excise from their insertion places and promote gene conversion 
in neurons) and k501 animals seem to have a similar level of effects on axon 
pathfinding, we decided to continue our genetic analysis with the k501 allele only. 
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tpa-1(k501) rack-1(tm2262) animals displayed only 1% PDE mutant axons, which 
would be consistent with both molecules acting in a linear pathway. In addition, 
tpa-1(k501); unc-115(ky275) animals displayed 10% of mutant axons (p<0.1), a 
non-significant increase (Figure 3.3D). 
 
PKC-2/cPKC and PKC-3/aPKC do not act at the UNC-115=RACK-1 level with 
the Rac GTPases in axon pathfinding. pkc-2(ok328) displayed 7% of PDE 
axon pathfinding defects alone. Although there was a slight increase in defects 
with mig-2(mu28) (to 18%, p<0.02), that was not significant. Neither were the 
interactions with ced-10(n1993) (12%, p<0.23), rack-1(tm2262) (3%, p<0.20) and 
unc-115(ky275) (14%, p<0.1) (Figure 3.3E). 
pkc-3(ok544M+) animals had to be maintained in a balancer heterozygous 
background (mInI) because of its early arresting stages (around the larval stages 
2 and 3 – L2/3). Therefore, a maternal contribution might still be present in the 
PDE neurons analyzed. Even with a maternal effect, double-mutant combinations 
of pkc-3(ok544M+) animals with unc-115(ky275) and rack-1(tm2262) were lethal 
probably by embryogenesis, and therefore we were not able to score them. 
Alone, pkc-3(ok544M+) displayed 25% of animals with a misguided PDE axon. 
Different from other pkc mutants, in which the axon misguidance would not be 
too severe (for example, they would still come out of the ventral side of the cell 
body and just fail to reach the ventral nerve cord in a wild-type manner – see 
materials and methods), pkc-3(ok544M+) mutant PDE axons would often have 
polarity defects as well (i.e., axons would come out of the lateral or dorsal side of 
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the cell body), and wander around in a much more severe way (often not making 
it all the way to the ventral nerve cord) (Figure 3.3B). This suggests PKC-3 is 
needed also for neuritogenesis and axon decision, polarity and pathfinding. 
When in combination with mig-2(mu28), pkc-3(ok544M+) mutants increased the 
PDE pathfinding defects seen to 38% (p<0.02); with ced-10(n1993), pkc-
3(ok544M+) mutants increased the defects observed to 32% (p<0.8), both of 
which were not statistically significant (Figure 3.3F). 
 
SRC-1 and SRC-2 possibly act in a different pathway that does not involve 
the Rac GTPases in PDE axon pathfinding. SRC-1 has Src-Homology (SH) 
SH3 and SH2 domains N-terminally, and a kinase domain C-terminally. src-
1(cj293) is a deletion that removes the SH2 domain and part of the kinase 
domain of the protein, causing a frame shift. This allele alone caused 8% of PDE 
neurons to fail in the proper extension of their axons. In a ced-10(n1993) 
background, 21% of PDE neurons were affected (p<0.01). Because this increase 
was significant, we did not pursue the interaction with the other components of 
this pathway, since we were targeting the most obvious candidates, and many 
intricate pathways could be envisioned to explain non-trivial genetic results 
obtained. Similarly, src-2(ok819) is a 2426bp deletion that removes portions of 
the four first exons of the src-2 gene. src-2 has not been reported to be 
expressed throughout the nervous system, so it was not surprising when we 
observed that src-2(ok819) displayed only 2% axon pathfinding defects, and in a 
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combination with either mig-2(mu28) or ced-10(n1993), src-2 did not enhance the 
defects observed (respectively, 6% - p>0.1 , and 5% - p>0.2) (Figure 3.5).  
 
The MIG-15/NIK possibly interacts with RACK-1 to modulate the activity of 
UNC-115/abLIM in PDE axon pathfinding downstream of CDC-42. An 
incomplete loss-of-function mutant allele of mig-15, called rh148, is a Val-168-
Glu missense mutation in the ATP-binding pocket of the kinase domain that likely 
disrupts its kinase activity. The putative null rh80 allele of mig-15 is a Trp-898-
stop mutation that yields in a premature stop codon that likely results in no 
protein expression or, if any, a non-functional truncated protein. mig-15(rh148) 
enhances the PDE axon pathfinding defects seen in both mig-2(mu28) and ced-
10(n1993) to levels similar to the null mig-15(rh80) allele. In addition, mig-
2(mu28) and ced-10(n1993) do not enhance the mig-15(rh80) allele, suggesting 
MIG-15/NIK acts with both MIG-2/RhoG and CED-10/Rac in this process. We 
wondered if MIG-15/NIK would be interacting at the UNC-115=RACK-1 level, 
since MIG-15/NIK has been reported in a yeast-two-hybrid to interact with RACK-
1. mig-15(rh148) animals had 35% of PDE axon pathfinding defects. A double-
mutant of mig-15(rh148) and rack-1(tm2262M+) displayed 49% defects (p<0.05). 
mig-15(rh80) displayed 47% defects on its own, which are very similar to the 
double mutant of mig-15(rh148);rack-1(tm2262) (p=0.78) (Figure 3.6A). 
Unfortunately, up-to-date experiments trying to recombine alleles of mig-15 and 
unc-115(ky275) have proven very difficult, therefore we do not have concrete 
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evidence of their genetic interaction yet. Nevertheless, other evidence suggests 
these molecules could be acting together. 
The Rho GTPase CDC-42 acts in parallel and upstream of Rac GTPases in the 
control of axon pathfinding in C. elegans. A constitutively activated form of CDC-
42, in which the Glycine in position 12 is changed to a Valine (Gly-12-Val), favors 
the GTP-bound state of this GTPase, and therefore constitutively activates it. 
cdc-42(G12V) animals displayed 55% of PDE neurons with ectopic lamellipodia 
(Figure 3.6B and C). Loss-of-function mutations in mig-15 and unc-115 
suppressed ectopic lamellipodial protrusions caused by overactive CDC-
42(G12V) (personal communication, data not shown). Therefore, we sought to 
determine if mutations in rack-1 would also suppress such defects. rack-
1(tm2262); cdc-42(G12V) animals displayed some robust suppression of such 
defects (37%, p<0.011) (Figure 3.6B). A double-mutant combination of the null 
allele of cdc-42(gk388) and rack-1(tm2262) was lethal even when balanced, and 
therefore we could not score these animals for defects. 
Because RACK-1 is a scaffolding protein that is probably required for the 
localization of the proteins involved in this process (i.e., UNC-115/abLIM), it is not 
too surprising that rack-1(tm2262) would only partially suppress the effects of 
CDC-42(G12V). Taken all together, we speculate RACK-1, UNC-115/abLIM and 
MIG-15/NIK could possibly be interacting together downstream of CDC-42, as 
well as CED-10/Rac, in PDE axon pathfinding (Figure 3.7). 
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3.4 Discussion 
We previously characterized a step-wise modulation pathway for the actin-
binding protein UNC-115/abLIM involving CED-10/Rac activation at the plasma 
membrane, followed by RACK-1 recruitment to the plasma membrane, and finally 
UNC-115/abLIM possible activation and localization via RACK-1. Because 
RACK-1 is a seven-bladed-WD scaffolding protein, it lacks any predicted 
activation domains and is possibly acting as a molecular assembler, recruiting 
different molecules together. Rack1-like molecules have been reported to interact 
with different classes of proteins involved in cell adhesion and migration, 
including the PKCs, Srcs, Integrins and Rho GTPase regulators. Since UNC-
115/abLIM could be putatively modulated by phosphorylation at the C-terminal 
VHD, where it binds to f-actin, we sought to determine if any of the most well 
known RACK-1 binding-partners would be modulating the activity of UNC-
115/abLIM. 
 
The novel PKCs TPA-1 and PKC-1 interact with the RACK-1=UNC-115 
complex downstream of CED-10/Rac. In our genetic screen of all four known 
pkc genes in the C. elegans genome, both pkc-1 and tpa-1 displayed a genetic 
interaction consistent with the hypothesis they act with the RACK-1=UNC-115 
complex downstream of CED-10/Rac. That all pkc genes showed a trend of 
synergy with mig-2/RhoG suggests a possible role of all pkc orthologs at this 
complex level, and that a possible redundancy or pleiotropy of PKC function 
might hide more clear effects. For example, PKC-3 might act with both CED-
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10/Rac and MIG-2/RhoG in particularly different pathways all leading to cell 
polarity and axon pathfinding. Nevertheless, it is clear to us that at least two PKC 
classes, PKC-1 and TPA-1, act with RACK-1 and UNC-115/abLIM in this 
pathway, and that PKC-1 is required cell-autonomously for this process. 
 
SRC kinases affect axon pathfinding possibly in a Rac-independent 
manner. Neither of the scr genes in C. elegans displayed a genetic interaction 
with mig-2/rhoG or ced-10/Rac consistent with them acting in linear pathways. In 
the case of SRC-2, where no significant increase was observed in axon 
pathfinding defects, one could argue SRC-2 and the RacGTPases could possibly 
interact in parallel but non-redundant pathways (since an additive effect could be 
hidden due to the fact either gene alone has a very low incidence of defects). 
However, the src-2 gene has not been reported to be expressed in the nervous 
system (at least not in the post-deirid where the PDE neurons are situated). 
Therefore, it was not too surprising to us that SRC-2 has no direct role in axon 
pathfinding. Mutations in src-1, however, display some minor but significant axon 
pathfinding defects. This shows SRC-1 has a role in axon pathfinding, and that it 
may act redundantly with the Rac GTPases. 
 
The NIK kinase MIG-15 possibly acts with RACK-1 and UNC-115/abLIM 
downstream of CDC-42 and the Rac GTPases in axon pathfinding. The 
serine-threonine kinase MIG-15/NIK has previously been implicated in acting with 
the Rac GTPases in PDE axon pathfinding. Moreover, a yeast-two-hybrid screen 
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has implicated RACK-1 as a binding partner of MIG-15/NIK. Because both UNC-
115/abLIM and MIG-15/NIK, and to some extend RACK-1, are needed for the 
ectopic lamellipodia caused by the overactivation of CDC-42, we speculate these 
molecules might be acting together during growth cone migration, and that MIG-
15/NIK could be controlling the activity of UNC-115/abLIM via RACK-1. 
In this work we have dissected another layer of activation needed for the actin-
binding UNC-115/abLIM during axonal development. Moreover, we have 
provided evidence that PKC signaling is involved in axon pathfinding and that it 
may cross-talk with the Rac GTPase signaling pathway at the level of the RACK-
1=UNC-115 complex. Other kinases, such as MIG-15/NIK, could also play a role 
in the proper control of UNC-115/abLIM during growth cone migration. The 
different proteins that could interact with UNC-115/abLIM for its proper 
modulation during axon pathfinding could reveal the different functions UNC-
115/abLIM might perform in order for an axon to reach its final target. 
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3.5. Materials and Methods 
Please refer to section 2.4 in Chapter II for PDE axon pathfinding scoring, 
molecular biology techniques and C. elegans culture. 
The following mutations and genetic constructs were used:  LGI: src-1(cj293), 
src-2(ok819), lqIs37[osm-6p::cdc-42(G12V)], hT1 I:V; LGII:  cdc-42(gk388), pkc-
3(ok544), mIn1[dpy-10(e128) mIs14]; LGIV: ced-10(n1993), rack-1(tm2262), tpa-
1(k501 and k530), nT1 IV:V, lqIs3[osm-6::gfp]; LGV:  pkc-1(ok563); LGX:  unc-
115(ky275), mig-2(mu28), pkc-2(ok328), lqIs2[osm-6::gfp]; LG?: lqIs14[osm-
6p::ced-10(G12V)], lqIs62[osm-6p::myr::unc-115], lqEx626 [osm-6p::myr::rack-1]. 
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Figure 3.1 
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Figure 3.1. A model for the activation of UNC-115/abLIM. Previous work has 
established that UNC-115/abLIM is activated in a step-wise manner. When at the 
plasma membrane, CED-10/Rac is at its GTP-bound form and therefore is active. 
It then recruits the scaffolding protein RACK-1, which will bind UNC-115/abLIM 
and possibly activate it with the help of other binding partners. 
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Figure 3.2 
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Figure 3.2. Schematic representations of the C. elegans PKCs, SRCs and 
MIG-15/NIK kinases. For PKC-1, PKC-2 and TPA-1, the longest isoforms were 
chosen for representation purposes. Diagrams based of BLAST domain 
predictions represented on Wormbase. All protein diagrams are followed by their 
amino-acid lengths (right-most number). C1= PKC conserved region 1; phorbol 
ester/DAG binding domain. C2= PKC conserved region 2; typically Ca2+-binding 
domain that targets protein to plasma membrane. PB1= Phox and Bem1 domain. 
SH3= Src Homology domain 3. SH3= Src Homology domain 2. PRD= Proline-
rich domain. CNH= Citron Homology domain. Kinase= kinase domain of the 
protein. 
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Figure 3.3 
 
 
 
 
 
 
 
 
0 2 4 6 8 10 12 14
mig-2(mu28)
ced-10(n1993)
rack-1(tm2262)
unc-115(ky275)
Percentage of PDE defects
A 
NS 
B 
wild type NS 
pkc-3(ok544M+) 
 94 
 
 
 
 
 
 
 
 
 
0 2 4 6 8 10 12 14
pkc-1(ok563)
pkc-1(ok563); mig-2(mu28)
pkc-1(ok563); ced-10(n1993)
pkc-1(ok563); rack-1(tm2262)
pkc-1(ok563); unc-115(ky275)
Percentage of PDE neurons
0 2 4 6 8 10 12 14
tpa-1(k501)
tpa-1(k530)
tpa-1(k501); mig-2(mu28)
tpa-1(k530); mig-2(mu28)
tpa-1(k501) ced-10(n1993)
tpa-1(k501) rack-1(tm2262)
tpa-1(k501); unc-115(ky275)
Percentage of PDE defects
C 
D 
* 
* 
* 
NS 
 95 
 
 
 
 
 
 
 
 
 
0 2 4 6 8 10 12 14 16 18 20
pkc-2(ok328)
pkc-2(ok328) mig-2(mu28)
pkc-2(ok328); ced-10(n1993)
pkc-2(ok328); rack-1(tm2262)
pkc-2(ok328) unc-115(ky275)
Percentage of PDE defects
0 5 10 15 20 25 30 35 40
pkc-3(ok544M+)
pkc-3(ok544M+); mig-2(mu28)
pkc-3(ok544M+); ced-10(n1993)
pkc-3(ok544M+); rack-1(tm2262)
pkc-3(ok544M+); unc-115(ky275)
Percentage of PDE defects
E 
F 
lethal 
lethal 
NS 
 96 
Figure 3.3. The four pkc genes interact differently with the Rac GTPases, 
unc-115/abLIM and rack-1 in PDE axon pathfinding. A Loss-of-function 
mutations in the Rac GTPases mig-2 and ced-10, in rack-1 and in unc-115/abLIM 
do not have a significant effect in PDE axon pathfinding. B Fluorescent 
micrographs of a wild-type and mutant PDE neuron. Dotted line indicates where 
the ventral nerve cord is situated. C Bar graph representing the PDE pathfinding 
defects in pkc-1(ok563) and double-mutant combinations with loss-of-function 
alleles of ced-10/Rac, mig-2/RhoG, rack-1 and unc-115/abLIM. D Same as C, but 
with tpa-1(k501) and tpa-1(k530). E Same as C, but with pkc-2(ok328). F Same 
as C, but with pkc-3(ok544). In all graphs, n=100 (unless otherwise noted); * = 
statistically significant (for p values, see results section); NS= not significant. 
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Figure 3.4 
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Figure 3.4. PKC-1 is needed for the ectopic lamellipodia caused by 
overactivation of CED-10/Rac, UNC-115/abLIM and RACK-1. A Bar graph 
representing the ectopic lamellipodia emanating from PDE neurons in different 
genotypes. *= statistically significant (for p values, see results section). B 
Fluorescent micrograph of a PDE neuron harboring the ced-10(G12V) transgene. 
An ectopic lamellipodium is depicted by the arrow. 
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Figure 3.5 
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Figure 3.5. The src genes do not act in a linear pathway with the Rac 
GTPases in axon pathfinding. Bar graph representing the PDE pathfinding 
defects in src-1(cj293), src-2(ok819) and double-mutant combinations with loss-
of-function alleles of ced-10/Rac and mig-2/RhoG 
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Figure 3.6 
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Figure 3.6. MIG-15/NIK and RACK-1 possibly act in a linear pathway 
downstream of CDC-42. A Bar graph representing the PDE pathfinding defects 
in mig-15 loss-of-function alleles and rack-1(tm2262). B Bar graph representing 
the ectopic lamellipodial protrusions emanating from the PDE neurons harboring 
an overactive cdc-42 transgene. C A fluorescent micrograph of a PDE neuron 
harboring the cdc-42(G12V) transgene. The arrow depicts the ectopic 
lamellipodia. 
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Figure 3.7 
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Figure 3.7. A genetic model of the stepwise activation of UNC-115/abLIM. 
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Chapter IV 
The Rac GEF TIAM-1 acts cell autonomously downstream of CDC-42 in the 
UNC-6/Netrin attractive pathway in in vivo axon pathfinding 
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4.1. Abstract 
In the developing nervous system, neurons extend axonal processes in 
order to communicate with other cells. When extending its axons, a neuron forms 
a dynamic, actin-rich growth cone that senses the surrounding environment for 
the proper migration cues through lamellipodial and filopodial structures. Racs 
are small GTPases from the Rho sub-family that are involved in the regulation of 
actin-binding proteins that can modulate the actin cytoskeleton. Racs are active 
when bound to GTP, and inactive when bound to GDP. GEFs - guanosine 
exchange factors - are molecules that aid Racs in the exchange of GDP for 
GTP, hence activating them. 
UNC-73/Trio is a well characterized GEF for the two redundant Racs 
CED-10/Rac1 and MIG-2/RhoG in C. elegans. However, a loss-of-function (lof) 
double mutant of mig-2 and ced-10 had more severe pathfinding defects than a 
lof of unc-73. While screening the other 18 DH-containing GEFs in the genome, a 
lof of tiam-1 displayed axon pathfinding defects when in combination with mig-2 
or ced-10. TIAM-1 is a GEF for Rac1 in mammals, and has been implicated in 
vitro in working downstream of Cdc-42. 
Our data suggest that in axon pathfinding in vivo, the previously 
uncharacterized GEF TIAM-1 acts upstream of the Rac GTPases. Moreover, we 
have evidence TIAM-1 could be the link between the CDC-42 and Rac pathways. 
Our data also suggest that TIAM-1 works downstream of the UNC-6/Netrin and 
UNC-40/DCC attractive signaling pathway. Future studies with other guidance 
receptors will further dissect the role of TIAM-1 in axon pathfinding. 
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4.2 Introduction 
In a developing nervous system, axonal growth happens via extension 
and migration of the growth cone, an actin-rich neuronal structure from which 
filopodial and lamellipodial structures emanate in order to sense the surrounding 
environment for appropriate guidance cues (Welch and Mullins 2002; Svitkina, 
Bulanova et al. 2003; Gallo and Letourneau 2004; Korobova and Svitkina 2008; 
Pak, Flynn et al. 2008).  Guidance receptors such as Deleted in Colorectal 
Carcinoma (DCC) and Roundabout (ROBO) are present in the leading edge of 
the growth cone and are activated upon ligand binding (such as Netrin and Slit, 
respectively) (Zallen, Yi et al. 1998; Brose, Bland et al. 1999; Shekarabi and 
Kennedy 2002; Gitai, Yu et al. 2003; Killeen and Sybingco 2008). Attractive and 
repellent guidance systems guide the growth cone towards its final target, 
presumably by affecting the protrusiveness of filopodial structures in the growth 
cone (Adler, Fetter et al. 2006; Killeen and Sybingco 2008) . The proper control 
of the actin cytoskeleton is crucial for the development, maintenance and 
dynamics of these filopodia and lamellipodia. Failure in the proper extension of 
axons during development is associated with several neurological disorders, 
including autism spectrum disorders and dyslexia (Hannula-Jouppi, Kaminen-
Ahola et al. 2005; Anitha, Nakamura et al. 2008). 
Rac GTPases, members of the Rho subfamily of small GTPases (which 
also includes Rho and Cdc-42), have been well established as modulators of the 
actin cytoskeleton (Bishop and Hall 2000). Rac GTPases and their downstream 
effectors modulate filopodia and lamellipodia morphology and dynamics during 
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axon pathfinding in vitro in mammalian cell culture, as well as in vivo in the fruit 
fly Drosophila melanogaster and the nematode Caenorhabditis elegans (Nobes 
1995; Azuma, Witke et al. 1998; Lundquist 2003; Biyasheva, Svitkina et al. 
2004). Rac GTPases act on the actin cytoskeleton via diverse downstream 
effectors such as the actin-filament nucleator Arp2/3 complex, the severing 
protein Cofilin, the Pak and LIM kinases, and the actin binding protein UNC-
115/abLIM (Symons 2000; Aizawa, Wakatsuki et al. 2001; Dan, Kelly et al. 2001; 
Pollard and Borisy 2003; Norris, Dyer et al. 2009). In C. elegans growth cone 
development and axon pathfinding, the two redundant Rac GTPases CED-
10/Rac and MIG-2/RhoG act via two distinct pathways to activate the Arp2/3 
complex: CED-10/Rac activates WVE-1/Wave, while MIG-2/RhoG activates 
WSP-1/Wasp (Shakir, Jiang et al. 2008). CED-10/Rac is also known to activate 
the actin-binding protein UNC-115/abLIM via recruitment of the Receptor for 
Activated C Kinase (RACK-1) (Demarco and Lundquist 2010). 
Although much is known about the downstream effectors of the Rac 
GTPases in axon development, not much is known about what controls their 
activity in vivo. Rac GTPases switch between an inactive, GDP-bound state, and 
an active, GTP-bound state. Rac GTPase activation can be reached with the aid 
of a Guanine-nucleotide Exchange Factor (GEF), which catalyzes the exchange 
of GTP for GDP (Hall 1992). GEFs have a greater affinity for GDP then Rac 
GTPases. When in contact with the GDP-bound Rac, GEFs facilitate the exit of 
GDP from the GTPase. Because the intra-cellular concentration of GTP is much 
higher than that of GDP (it is estimated to be about 10x greater), a GTP molecule 
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can then enter the GTP-binding pocket of the Rac GTPase for its activation 
(Schmidt and Hall 2002). 
UNC-73/Trio is a well characterized GEF for MIG-2/RhoG and CED-
10/Rac in C. elegans axon pathfinding (Steven, Kubiseski et al. 1998; Lundquist, 
Reddien et al. 2001; Wu, Cheng et al. 2002; Kubiseski, Culotti et al. 2003). In its 
longest isoform (F55C7.7a, see Wormbase), UNC-73/Trio has eight spectrin 
repeats N-terminally, followed by a RacGEF-specific Double Homology 
(DH)/Pleckstrin Homology (PH) domain, an SH3 domain, a RhoGEF-specific 
DH/PH domain, an Immunoglobulin domain and a Fibronectin Type-III domain 
(Figure 4.1D). A mutation that disrupts specifically the RacGEF activity of UNC-
73/Trio (rh40, see Figure 1D) disrupts axon pathfinding. Nevertheless, total 
abolishment of Rac GTPase activity in C. elegans has more severe defects in 
axon pathfinding (Lundquist, Reddien et al. 2001). 
Here we show that another GEF, the previously uncharacterized C. elegans 
counterpart of human Tiam1 (henceforth called TIAM-1), is involved in the 
upstream modulation of Rac GTPases for axon pathfinding. 
 
4.3 Results 
 
T21E12.2 and C11D9.1 are one single gene and code for a GEF similar to 
mammalian Tiam1. The C. elegans Rac GTPases MIG-2/RhoG and CED-
10/Rac1 act redundantly in PDE axon pathfinding (Lundquist, Reddien et al. 
2001). Loss-of-function mutations in either mig-2 or ced-10 alone did not disturb 
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significantly the pathfinding of the PDE axons (1% and 0%, respectively), but 
when in a double mutant combination (mig-2(mu28); ced-10(n1993M+)), most 
PDE neurons were affected (84%, Figure 4.2 and (Lundquist, Reddien et al. 
2001)). UNC-73/Trio is a well characterized GEF for MIG-2/RhoG and CED-
10/Rac1 in axon pathfinding (Steven, Kubiseski et al. 1998). A mutation that 
specifically abolishes the Rac GEF activity of UNC-73 (rh40, a Ser-1216-Phe 
substitution in the Rac-specific DH1 domain) displayed severe axon pathfinding 
defects (42%, Figure 4.2), but not as strong as the double mutant of mig-
2(mu28); ced-10(n1993M+) (p<0.0001). When in combination with either mig-
2(mu28) or ced-10(n1993), unc-73(rh40) synergizes to similar levels as mig-
2(mu28); ced-10(n1993M+) in axon pathfinding (Lundquist, Reddien et al. 2001). 
These results suggest there might be other GEF(s) acting in parallel to UNC-73 
in axon pathfinding. 
The C. elegans genome encodes a total of 19 predicted DH-containing 
GEFs. From a screen we performed of the other 18 DH-containing GEFs (with 
either deletion alleles or RNAi), we found two alleles of C11D9.1 (ok772 and 
tm1556) that showed synthetic synergy with mig-2(mu28) and ced-10(n1993) in 
PDE axon pathfinding (Figure 4.2). ok772 had only 1% of affected PDEs, but 
when in combination with mig-2(mu28), it  had 6% of PDEs misrouted (p<0.001), 
and with ced-10(n1993), 14% (p<0.001). tm1556 displayed 2% of PDE 
pathfinding defects on its own, but increased defects in mig-2(mu28) to 15% 
(p<0.001), and in ced-10(n1993) to 12% (p<0.005).   
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We then obtained three isolated cDNAs containing sequence 
complimentary to C11D9.1 (courtesy of Yuji Kohara). To our surprise, the cDNAs 
contained sequences complimentary not only to C11D9.1, but also to the 
predicted gene T21E12.2, in one single message (Figure 4.1A,B,C). After 
searching for the cDNA sequences within the genome of other organisms using 
BLAST, we found the combined message codes for a putative Rac GEF domain 
composed of a Double Homology (DH) followed by a Pleckstrin Homology (PH) 
domain, similar to mammalian Tumor Invasive and Metastasis Factor-1 (Tiam1). 
In other nematodes, insects and mammals, Tiam1-like proteins have other 
domains than just the DH/PH, which direct protein localization and function 
(Hoshino, Sone et al. 1999; Matsuo, Hoshino et al. 2002). In order to  test if C. 
elegans TIAM-1 would have other putative functional domains as well, we 
performed a targeted BLAST search of small regions of the TIAM-1 amino-acid 
sequence against Still Life/Tiam1 from Ascaris suum, an evolutionarily diverse 
nematode. If recognized, this region would then be searched for in Drosophila 
melanogaster Still Life/Tiam1 for further comparison (Figure 4.S1). Using the 
longest cDNA (H9) as a model, C. elegans TIAM-1 putatively has an N-terminal 
EVH1/PH domain (amino-acids 1-100), followed by a PDZ domain (amino-acids 
398-486) (Figure 4.1A,B,C). Although we do not claim these are bona fide EVH1 
and PDZ domains, it is possible that these domains are still functioning in a way 
similar to their counterparts in other organisms. Future work will dissect the roles, 
if any, of these putative functional domains. 
 112 
In other organisms, the DH-PH domain of Tiam1 is Rac specific 
(Worthylake, Rossman et al. 2000; Matsuo, Terao et al. 2003). Both alleles used 
in the screen (ok772 and tm1556) remove at least part of the DH domain of 
TIAM-1. ok772 is a 18bp insertion (CTGTAACTTAACTGTAAC) and an out-of-
frame 838bp deletion that removes exon 15 of the gene (region coding part of the 
DH and PH domains), and tm1556 is an out-of-frame 851bp deletion that 
removes exons 11, 12 and 13 of the gene (region coding part of the DH domain) 
(Figure 4.1A,B,C). In both cases, even if any protein were to be made, it would 
not contain the DH-PH domains, which are responsible for its GEF activity. 
 
tiam-1 is expressed primarily in the nervous system and controls different 
aspects of neuronal development. We next sought to determine where tiam-1 
is expressed. We amplified the region upstream of T21E12.2 until reaching the 
next open reading frame (a region of 4793bp), and placed it upstream of the cyan 
fluorescent protein (cfp) gene. When nematodes were made transgenic, this 
reporter construct was expressed primarily in the nervous system (Figure 4.3A). 
Many neurons in the head and tail, as well as throughout the body of the animal 
expressed CFP, including the GABAergic and cholinergic neurons (V and D-
types) in the ventral nerve cord, ALM, CAN, PDE, PVD, AVM and PVM (Figure 
4.3A). tiam-1 expression began in embryos and lasted throughout adulthood. 
Because of its broad expression in the nervous system, we decided to test 
whether if tiam-1 controls development in neurons other than the PDEs (utilized 
in our screen). tiam-1(ok772) was crossed to zdIs4(mec-4p::gfp), which is a 
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marker for touch-sensory neurons including AVM (Figure 4.3B), and juIs76(unc-
25p::gfp), which illuminates the GABAergic motorneurons VDs and DDs (Figure 
4.3C). In both cases, tiam-1(ok772) displayed some minor neuronal 
developmental defects. The AVM neuron is located in the anterior part of the 
nematode, and its cell body resides in the middle right side of the animal. It 
extends an axon until reaching the ventral nerve cord, where it turns anteriorly 
and extends its axon till close to the nerve ring. In these neurons, tiam-1(ok772) 
showed 1% axon pathfinding defects, 6% ectopic neurite occurrence and 10% 
ectopic lamellipodia occurrence. None of these phenotypes were ever seen in 
wild type animals (data not shown). 
The VD and DD motorneuron nuclei are situated in the ventral nerve cord. 
They each first extend an axon anteriorly, then a branch turns dorsally and 
extends in a right angle until reaching the dorsal nerve cord, where it extends 
anterior and posteriorly. Usually more than one motorneuron axon will follow the 
same commissure in the animal. In these neurons, tiam-1(ok772) did not show 
defects on its own, but synergized significantly to the defects caused by unc-
73(rh40). unc-73(rh40) showed many defects in the VD and DD neurons, 
including axon pathfinding (26.15% of axons), ectopic branching of the 
commissures (20.76% of commissures) and failure of P-cell migration (the 
precursor cells of the VDs) to locate to the ventral nerve cord (20% of animals). 
unc-73(rh40) tiam-1(ok772) animals had 51.45% of axon pathfinding defects, 
50.43% ectopic branches coming out of the axonal commissures, and 60% of 
animals with P-cell migration defects. These results are consistent with the idea 
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TIAM-1 is needed in the nervous system for different aspects of development, 
and that it acts in a different pathway than UNC-73/Trio. 
 
Loss-of-function mutations in tiam-1 showed additive effect when in 
combination with unc-73(rh40) in the pathfinding of PDE axons. As 
mentioned previously, both ok772 and tm1556 alleles of tiam-1 synergized to 
significant levels with ced-10(n1993) and mig-2(mu28) in PDE axon pathfinding 
(Figure 4.2). In order to determine if TIAM-1 and UNC-73 act in a linear or 
parallel pathway, we created double mutant combinations of unc-73(rh40) with 
either allele of tiam-1. unc-73(rh40) alone displayed 42% of PDEs affected. 
Interestingly to us, neither ok772 nor tm1556 alleles of tiam-1 seemed to 
synergize with unc-73(rh40) (51% and 57%, respectively. p=0.2 when compared 
to unc-73(rh40) only). Because neither ok772 not tm1556 display significant 
defects on their own, they could have a rather additive increase when combined 
with unc-73(rh40) (Figure 4.2). One explanation would be that although these two 
GEFs work in parallel pathways in the control of axon pathfinding, they are not 
totally redundant and may have specific functions in the activation of the Rac 
GTPases (e.g., TIAM-1 might be acting in the filopodia-protrusive activation of 
Rac GTPases, while UNC-73 might be acting in the filopodia-retractive activation 
of Rac GTPases). Another explanation would be that TIAM-1 works 
independently of the UNC-73/MIG-2/CED-10 pathway, and therefore would 
increase the number of defects in both GTPases and UNC-73 because it does 
not work in the same pathway as they. 
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TIAM-1 acts upstream of MIG-2/RhoG and CED-10/Rac1 in PDE axon 
pathfinding. In order to test the hypothesis that TIAM-1 acts in a linear pathway 
upstream of CED-10/Rac1 and MIG-2/RhoG, we created a constitutively 
activated form of this molecule. Because the DH/PH domains are essential and 
sufficient to facilitate the exchange of GTP for GDP in the GTPases, and 
because there is evidence for different intramolecular inhibition mechanisms in 
different GEFs, we decided to amplify the DH/PH region and overexpress it in the 
PDE neurons. In Drosophila Trio, a similar construct has been made and it acted 
as if constitutively active (Seipel, Medley et al. 1999). 
We cloned the DH/PH region of TIAM-1 (amino-acids 488 - 856), added 
an N-terminal myristoylation sequence (to ensure this construct would go to the 
plasma membrane), and fused it C-terminally with GFP. We placed this construct 
under the control of the PDE promoter osm-6. As controls, we also amplified and 
cloned the DH/PH regions of UNC-73 (DH1/PH1 is Rac specific – amino-acids 
1193 - 1527, DH2/PH2 is Rho specific – amino-acids 1795 - 2129; all amino-acid 
positioning is based on the longest isoform of UNC-73 – F55C7.7a) as described 
for TIAM-1. 
When expressed in transgenic animals, the DH1/PH1 of UNC-73/Trio and 
DH/PH of TIAM-1 promoted ectopic lamellipodial and filopodial protrusions that 
emanated from the cell body and axons of PDEs (51% and 34% respectively). 
Axon branching and defects in pathfinding also occurred in a lesser scale. The 
DH2/PH2 of UNC-73, which is Rho specific, did not cause any significant defects 
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(1%). This is consistent with the hypothesis these GEFs are recruited to the 
plasma membrane for the activation of Rac GTPases. Hence the ectopic 
lamellipodial and filopodial projections seen could be equivalent to the 
lamellipodial and filopodial structures present in the developing growth cones of 
these axons, which are primarily controlled by Rac GTPases. In addition to our 
controls, we mimicked the rh40 mutation (that changed Ser-1216-Phe) in our 
DH1/PH1 construct of UNC-73/Trio (Ser-11-Phe in the construct), and made an 
equivalent substitution (Thr-516-Phe) in the DH/PH of TIAM-1 (Thr-08-Phe in the 
construct). Both constructs were expressed (as seen by the expression of the 
tagged GFP), but neither promoted significant ectopic lamellipodial protrusions 
(1% for UNC-73[DH1(Ser-11-Phe)/PH1] and 6% for TIAM-1[DH(Thr-08-
Phe)/PH]). 
Next, we crossed loss-of-function mig-2 and ced-10 with these overactive 
constructs to test for suppression of the ectopic lamellipodia/filopodia phenotype. 
When using overexpression transgenes, we were careful to outcross the 
transgene away from the loss-of-function and re-score the transgene to ensure it 
had not broken down and lost the effect. Therefore, for each experiment (i.e., for 
each loss-of-function rac gene), we outcrossed the transgene and re-scored it as 
control. Both mig-2(mu28) and ced-10(n1993) were able to significantly suppress 
the ectopic lamellipodial/filopodial projections caused by constitutively activated 
UNC-73/Trio and TIAM-1 (Fig4). mig-2(mu28) suppressed the ectopic 
lamellipodia and filopodia caused by UNC-73[DH1/PH1] (96% to 44%, p<0.0001) 
and TIAM-1[DH/PH] (74.51% to 23%, p<0.0001). Likewise, ced-10(n1993) also 
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significantly suppressed this phenotype in both UNC-73[DH1/PH1] (93% to 79%, 
p<0.003) and TIAM-1[DH/PH] (48% to 13%, p<0.0001). Together with the loss-
of-function data, these results suggest TIAM-1 acts upstream and in a linear 
pathway with both MIG-2/RhoG and CED-10/Rac1 in axon pathfinding, and that 
TIAM-1 acts in a parallel pathway to UNC-73/Trio. 
 
TIAM-1, but not UNC-73/Trio, acts downstream of CDC-42. Evidence from cell 
culture studies (Nishimura, Yamaguchi et al. 2005) suggests mammalian Tiam1 
acts downstream of Cdc-42 in the activation of Rac1. In order to investigate if 
TIAM-1 acts downstream of CDC-42 in axon pathfinding in vivo, we first built 
loss-of-function double mutants of tiam-1 and cdc-42. tiam-1(ok772);cdc-
42(gk388M+) did not increase in the amount of defective PDE axon pathfinding. 
This result is consistent with the hypothesis that CDC-42 and TIAM-1 work in the 
same pathway. A Gly-12-Val substitution in the GTPase binding pocket of small 
GTPases has been shown to favor the GTP-bound state of these molecules, 
constitutively activating them (Struckhoff and Lundquist 2003) . Transgenic 
animals harboring an integrated array of cdc-42(G12V) under the control of the 
osm-6 promoter display ectopic lamellipodial and filopodial protrusions (44%), as 
well as disruption of proper axon pathfinding (50%) in the PDE neurons. When 
crossed to tiam-1(ok772) or tiam-1(tm1556), both phenotypes were significantly 
suppressed (12% and 8% for ok772, 8% and 10% for tm1556, in all cases 
p<0.000001). As a control, we re-introduced tiam-1 in these animals by crossing 
an extra-chromosomal fosmid containing tiam-1 under its endogenous promoter, 
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and most strongly the ectopic lamellipodia and filopodia phenotype seen in cdc-
42(G12V) came back (56% and 15% for ok772, 61% and 15% for tm1556) 
(respectively, p<0.001, p<0.06, p<0.001 and p<0.1). Together, these data 
suggest TIAM-1 acts downstream of CDC-42 for proper axon guidance. 
We also analyzed double mutants of unc-73(rh40);cdc-42(gk388M+). Animals 
carrying both mutations displayed a synergistic increase in the number of PDE 
pathfinding defects (90%, p<0.001). In addition, when crossed into cdc-42(G12V) 
animals, unc-73(rh40) did not suppress the ectopic defects caused (47% for 
lamellipodia/filopodia, 71% for pathfinding). Hence UNC-73/Trio does not seem 
to act with CDC-42 in PDE axon pathfinding. 
 
TIAM-1 localizes to the plasma membrane of neurons and NIH3T3 
fibroblasts. To determine the localization of TIAM-1 in neurons, we amplified the 
coding region of tiam-1 based on its longest cDNA (H9), fused it C-terminally with 
mcherry, and placed this construct under the control of either the unc-25 (VD/DD-
specific) or osm-6 (PDE-specific) promoter. In the PDE and VD/DD 
motorneurons, TIAM-1::mCherry localized primarily to the periphery of the cell 
bodies, consistent with a plasma membrane localization. When active, Rac 
GTPases localize to the plasma membrane. The fact that TIAM-1::mCherry also 
localized to the plasma membrane suggests a possible interaction between these 
molecules. To verify if that is the case, animals containing unc-25p::gfp::ced-10 
or unc-25p::gfp::mig-2 were generated and observed for Rac localization in the 
VD/DD motorneurons. In these cells, GFP::CED-10 and GFP::MIG-2 were 
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enriched at plasma membrane (Figure 4.6). TIAM-1::mCherry, GFP::CED-10 and 
MIG-2 were also found in the growth cone of the developing VD neurons. Such 
localization supports the idea these molecules are required for proper re-shaping 
of the growth cone during axon pathfinding. We also tested the possibility that 
CDC-42 controls the localization of TIAM-1 in the neuron (Figure 4.6). We 
analyzed the localization pattern of TIAM-1::mCherry in PDE and VD/DD neurons 
in a cdc-42(gk388M+) background, but we did not notice any significant change 
of protein accumulation in these mutants (data not shown). 
C. elegans neurons are very small in scale. Although TIAM-1 and the 
Racs seem to be present at the plasma membrane, we could not rule out the 
possibility these molecules were just being excluded from the nucleus (they could 
have a cytoplasmic localization pattern instead). In addition, due to the poor 
signal, we were not able to obtain convincing co-localization data between TIAM-
1 and the Racs at the plasma membrane. Therefore, we analyzed the localization 
pattern of TIAM-1 and CED-10 in NIH-3T3 fibroblasts. Full –length TIAM-1 and 
CED-10 molecules were amplified from their respective cDNAs using PCR and 
fused in frame N-terminally with either mCherry or GFP, respectively. The 
overexpression of GFP::CED-10 in fibroblasts caused them to ruffle, a phenotype 
previously observed by the overexpression of Rac (Nobes 1995). GFP::CED-10 
localized to some intracellular membraneous organelles (presumably the 
endoplasmic reticulum) and plasma membrane (Figure 4.7A). The 
overexpression of mCherry::TIAM-1 did not affect cell shape, and 
mCherry::TIAM-1 also localized to the plasma membrane and intracellular 
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membraneous organelles (Figure 4.7A). These localization patterns were 
different than those observed by the expression of the empty vectors (Figure 
4.7A).  When expressed together, mCherry::TIAM-1 and GFP::CED-10 co-
localized strongly to membraneous organelles, and to certain domains of the 
plasma membrane (Figure 4.7B). These data support the idea TIAM-1 and 
RacGTPases co-localize at the plasma membrane for Rac activation, and that 
this interaction is transient (since only a few domains of co-localization were 
observed). 
 
TIAM-1 acts cell-autonomously in PDE axon pathfinding. As previously 
mentioned, cdc-42(G12V) causes ectopic lamellipodial protrusions and axon 
pathfinding defects that are dependent on tiam-1 in the PDE neurons (since the 
loss-of-function alleles of tiam-1 suppressed the phenotypes). When crossed to 
cdc-42(G12V) tiam-1(ok772), two lines of osm6p::tiam-1::mcherry (at 10 and 
100ng/µL) were able to restore the defects caused by cdc-42(G12V) (70% and 
76% respectively). A similar trend happened when cdc-42(G12V) tiam-1(tm1556) 
was used (57% and 64% for the 10 and 100ng/µL lines, respectively). These 
results suggest TIAM-1 acts cell-autonomously within the PDE neurons in axon 
pathfinding and that TIAM-1 is needed for the ectopic protrusions caused by 
overactive CDC-42. 
 
TIAM-1 acts as a GEF for Rac, but not Cdc-42 nor Rho in an in vitro mant-
GTP exchange assay. Genetic data implicated TIAM-1 acting in a linear 
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pathway with CDC-42 and CED-10/Rac1 and MIG-2/RhoG. Although TIAM-1 has 
a predicted Rac-specific DH domain, there is a possibility TIAM-1 could be 
working indirectly in the activation of CED-10/Rac1 and MIG-2/RhoG (i.e., TIAM-
1 could recruit other molecules that would then activate the Racs, or could only 
act as a scaffold for Rac recruitment). In order to investigate mechanistically the 
role of TIAM-1 in the activation of Rac GTPases, we measured the exchange 
rates of mant-GTP incorporation by the GTPases in the presence or absence of 
TIAM-1 in vitro, using the RhoGEF exchange assay Biochem Kit from 
Cytoskeleton. 
N- methylanthraniloyl-GTP (mant-GTP) is a fluorescently labeled 
nucleotide analog that can be incorporated by small GTPases. We measured the 
amount of mant-GTP incorporated by the GTPase due to the spectroscopic 
difference between bound and free mant-GTP (when in the GTPase binding 
pocket, mant-GTP increases its fluorescence). 
We amplified from the TIAM-1 cDNA a region containing the DH and PH 
domains, and cloned it in frame with a 6 Histidine tag into a pET-28b vector 
(EMD Biosciences). We then expressed and purified the protein (TIAM-
1[DH/PH]) and purified using a Ni+-column based affinity chromatography. 
After five minutes of incubation with mant-GTP and buffer, the GTPase (human 
Rac1, Cdc-42 or RhoA) was exposed to either solvent (control) or GEF (TIAM-
1[DH/PH]). 
In the absence of GEF, none of the GTPases seems to incorporate mant-
GTP (the fluorescence does not change over the time of 30min). In the presence 
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of TIAM-1[DH/PH], the fluorescence readings from Rac1, but not Cdc-42 nor 
RhoA, dramatically increased, suggesting mant-GTP is being incorporated by 
Rac1 in the presence of TIAM-1[DH/PH]. We then introduced the Thr-08-Phe 
mutation that putatively abolishes the GEF activity of this molecule into this 
construct. When performing the mant-GTP exchange assay with TIAM-1[DH(Thr-
08-Phe)/PH], the fluorescence readings of Rac1 did not increase significantly, 
suggesting this point mutation indeed disrupts the guanosine exchange activity of 
TIAM-1[DH/PH]. 
Because human Rac1 and Cdc-42 are similar to their C. elegans 
counterparts (90-95% amino-acid similarity to CED-10 and CDC-42), we believe 
C. elegans TIAM-1 is a Rac-specific GEF and works with CED-10/Rac and MIG-
2/RhoG, but not CDC-42, in axon pathfinding. 
 
TIAM-1 acts in the UNC-6/Netrin-UNC-40/DCC attractive signaling pathway 
in parallel to SLT-1/Slit-SAX-3/Robo and VAB-1/EphR pathways. In order to 
identify under which guidance pathway TIAM-1 would be acting, we crossed 
tiam-1(ok772) into loss-of-function alleles of the different parallel ventral 
guidance pathways present in C. elegans. UNC-6/Netrin is a secreted ligand 
expressed in the ventral side of the animal that attracts axons that express its 
receptor UNC-40/DCC (Hedgecock, Culotti et al. 1990). SLT-1/Slit is expressed 
primarily in the dorsal side and is thought to act as a repellent for ventrally-guided 
axons that express its receptor SAX-3/Robo (Hao, Yu et al. 2001). Besides these 
two major pathways, Ephrins have also been involved in directing proper axon 
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pathfinding (Flanagan and Vanderhaeghen 1998). VAB-1/EphR is the only C. 
elegans Ephrin receptor and has been shown to work in parallel with UNC-
6/Netrin and SLT-1/Slit in axon ventral guidance (Zallen, Kirch et al. 1999). 
tiam-1(ok772) did not increase the amount of PDE pathfinding defects of 
unc-6(ev400) (from 59% to 56%), but did significantly increase the defects of 
vab-1(dx31) (from 4% to 46%, p<0.001) and slt-1(eh15) (11% to 22%, p=0.037). 
In addition, we can constitutively activate the UNC-40/DCC Netrin receptor by 
fusing its cytoplasmic domain N-terminally to a myristoylation sequence. (Gitai, 
Yu et al. 2003) have previously shown that in the AVM neurons (also ventrally 
guided and responsive to UNC-6/Netrin), ectopic lamellipodial-like protrusions 
emanate from the cell body when activated UNC-40 (myr::cytoUNC-40) is 
expressed, and that UNC-73 was not required for such effects. In our hands, 
myr::cytoUNC-40 displayed 53% of AVMs with ectopic lamellipodial-like 
structures. unc-73(rh40) indeed did not suppress such defects (58%), confirming 
the results previously described by Gitai et al. (2003).  Nevertheless, tiam-
1(ok772) significantly suppressed the ectopic lamellipodia incidence in these 
neurons (down to 22%, p<0.001). Adding together the loss- and gain-of-function 
data, we believe TIAM-1 works in the UNC-6/UNC-40 attractive pathway, in 
parallel to SLT-1/SAX-3 and VAB-1, for the axon ventral guidance. 
 
4.4 Discussion 
In this report we identified the C. elegans protein TIAM-1 and presented evidence 
that IAM-1 acts specifically as a GEF for Rac GTPases in axon pathfinding. We 
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presented evidence that TIAM-1 might act upstream of the two redundant Rac 
GTPases MIG-2/RhoG and CED-10/Rac, and downstream of CDC-42 and the 
UNC-6/Netrin attractive signaling pathway. 
Previous studies have demonstrated that the guanine exchange factor UNC-
73/Trio acts with CED-10/Rac and MIG-2/RhoG in axon pathfinding. 
Nevertheless, mutations that disrupted the Rac GEF specific domain of UNC-
73/Trio did not display axon pathfinding defects as penetrant as those seen in the 
complete abolishment of Rac activity (i.e., in the mig-2;ced-10 double mutant). In 
addition, despite the fact CED-10/Rac and the actin-binding protein UNC-
115/abLIM have been suggested to act downstream of the UNC-6/Netrin-UNC-
40/DCC attractive signaling pathway, UNC-73/Trio did not seem to be part of this 
signaling cascade. Together, this evidence led us to conclude there must be 
other factors, possibly GEFs, acting upstream of MIG-2/RhoG and CED-10/Rac 
for their proper activation in axon pathfinding. After performing a genetic screen 
for the other 18 DH-containing GEF genes in the C. elegans genome, we 
observed a genetic interaction between tiam-1 and the Rac GTPases. 
 
TIAM-1 acts cell-autonomously in axon pathfinding. The tiam-1 gene is 
expressed primarily, if not exclusively, in the nervous system. tiam-1(ok772) and 
(tm1556) mutant animals displayed defects alone and in combination with Rac 
GTPase mutants in axon guidance in different types of neurons, including the 
commissural VD and DD GABAergic motorneurons and the ciliated serotonergic 
PDE neurons. The fact that the VD and DD axons are dorsally attracted and the 
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PDE axons are guided ventrally suggest TIAM-1 is required for not just one type 
of neuronal guidance. In PDE neurons, overactivation of CDC-42 cause ectopic 
ectopic lamellipodial and filopodial structures that resemble those seen in axonal 
growth cones. TIAM-1 molecules expressed specifically in the PDEs are required 
for such a phenotype, since TIAM-1 removal suppressed the ectopic lamellipodia 
and filopodia seen in CDC-42-overactive PDEs. In sum, we presented strong 
evidence that TIAM-1 acts cell-autonomously in axon guidance. 
 
TIAM-1 acts upstream of MIG-2/RhoG and CED-10/Rac and downstream of 
CDC-42 in axon pathfinding. A proposed model for the role of TIAM-1 in axon 
pathfinding is seen in Figure 4.10. Epistasis analysis with loss- and gain-of-
function mutants have shown a genetic interaction between TIAM-1 and the 
GTPases MIG-2 and CED-10. Because a loss of activity of either GTPase 
suppressed overactivated TIAM-1, we concluded TIAM-1 acts upstream of MIG-
2/RhoG and CED-10/Rac. In addition, biochemical (mant-GTP based exchange 
assay) and cell biological (co-localization studies) data supports the model in 
which TIAM-1 acts as a GEF for the activation of Rac GTPases in C. elegans. 
 In vitro studies of human Cdc-42 and Tiam1 have suggested these 
molecules act in the same pathway. Moreover, hTiam1 has been implicated as a 
downstream effector of hCdc-42. In order to test this hypothesis in vivo, we 
analyzed both loss- and gain-of-function CDC-42 combinations with both loss-of-
function alleles of TIAM-1. It seems that also in vivo C. elegans TIAM-1 acts in a 
linear pathway downstream of CDC-42 for axon guidance. 
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The UNC-6/Netrin-UNC-40/DCC signaling machinery recruits TIAM-1 for its 
effect on attraction of axon guidance. UNC-6/Netrin is the ventrally-expressed 
ligand for the UNC-40/DCC receptor present in ventrally-attracted axons. Several 
reports have elucidaded some of the intracellular machinery required 
downstream of the UNC-40/DCC attractive response. The Rac GTPase CED-10 
and the actin-binding protein UNC-115/abLIM act downstream of UNC-40/DCC, 
but not the Rac GEF UNC-73/Trio. We then tested whether or not TIAM-1 would 
be the GEF recruited in this pathway. TIAM-1 suppressed the ectopic 
lamellipodial structures caused by an overactive construct of UNC-40 in AVM 
neurons, which are also attracted to UNC-6/Netrin. In addition, tiam-1 and unc-
6/Netrin seem to act in a linear pathway, in parallel to other guidance systems 
such as SLT-1/Slit and VAB-1/Eph. 
 In summary, we have presented evidence that TIAM-1 acts cell-
autonomously in the control of axon pathfinding, and that it does so by facilitating 
the exchange of GTP for GDP in the Rac GTPases CED-10/Rac and MIG-
2/RhoG. We have also shown that TIAM-1 acts downstream of CDC-42, linking 
both CDC-42 and Rac GTPase signaling together. Moreover, we demonstrated 
that TIAM-1 is the GEF used in the protrusive, attractive signaling pathway 
mediated by UNC-6/Netrin and UNC-40/DCC in ventrally guided neurons. Future 
work will focus on the detailed growth cone observations of the mechanisms by 
which TIAM-1 controls filopodial and lamellipodial dynamics. 
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4.5 Materials and Methods 
 
C. elegans genetics and culture: C. elegans handling and culture were 
performed using standard techniques (Brenner 1974; Sulston and Hodgkin 
1988).  All experiments were performed at 20oC.  The tiam-1(tm1556) allele was 
provided to us by the National Bioresource Project for the Experimental Animal 
“Nematode C. elegans” (S. Mitani), and the tiam-1(ok772) allele was provided to 
us by the C. elegans Gene Knockout Consortium via the C. elegans Genetic 
Center (CGC).  Polymerase chain reaction (PCR) was used to verify the 
homozygosity in the tiam-1(ok772) and (tm1556) in strains.  The following 
mutations and genetic constructs were used:  LGI: unc-73(rh40), tiam-1(ok772) 
and (tm1556), lqIs37[osm-6::cdc-42(G12V)]; LGII:  cdc-42(gk388), mIn1,vab-
1(dx31),  juIs76[unc-25::gfp]; LGIV: ced-10(n1993), zdIs4[mec-4::gfp], lqIs3[osm-
6::gfp]; LGV:  lqIs123[osm-6::myr::unc-73(DH1/PH1)]; LGX: mig-2(mu28), unc-
6(ev400), slt-1(eh15), lqIs2[osm-6::gfp]; LG?:  lqIs125[osm-6::myr::unc-
73(DH2/PH2)], lqIs131[mec-7::myr::unc-40(cyto)::gfp],  lqIs134[osm-6::myr::unc-
73(DH1-S11F-/PH1)], lqIs165[osm-6::myr::tiam-1(DH/PH)], lqIs193[osm-
6::myr::tiam-1(DH-T08F-/PH)].  C. elegans transformation was performed with 
standard methods by microinjection of DNA into the hermaphroditic syncytial 
germline (Epstein and Shakes 1995).  Transgenes were integrated into the 
genome using trimethylpsoralen and standard techniques (Mello, Kramer et al. 
1991; Anderson 1995). 
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 All micrographs were obtained on a Leica DMRE microscope with a 
Qimaging Rolera MGi EMCCD camera or a Qimaging Retiga CCD camera.  
Openlab and IPlab software were used to obtain images. 
 
Molecular biology: Coding region sequencing was performed after PCR 
amplification to verify for any possible undesirable mutations.  Molecular biology 
techniques were performed as previously described (Sambrook 1989).  Primer 
and plasmid sequences are available upon request. 
 
Scoring of PDE, VD/DD and AVM axon defects:  Fluorescence microscopy 
was used to score axon pathfinding defects of fourth larval stage (L4) or young 
adult hermaphrodite animals expressing a green fluorescent protein transgene 
for specific cells. To score and visualize PDE axons, the integrated transgenes 
lqIs2 X and lqIs3 IV [osm-6 promoter::gfp] were used (Collet, Spike et al. 1998; 
Struckhoff and Lundquist 2003).   To score and visualize VDs and DDs axons, 
the integrated transgene juIs76 II [unc-25 promoter::gfp] was used (Jin, 
Jorgensen et al. 1999). To score and visualize AVM axons, the integrated 
transgene zdIs4 IV [mec-7 promoter::gfp] was used. PDE axon pathfinding:  The 
cell bodies of the PDE neurons (PDEL and PDER) are situated in the posterior 
lateral post-deirid ganglion.  PDEs extend an axon ventrally to the ventral nerve 
cord, which then bifurcates and extends anteriorly and posteriorly in the ventral 
nerve cord.  If the axon failed to reach the ventral nerve cord or wandered 
beyond a 45o angle from a straight line ventrally from the cell body, it was 
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considered mutant. VD/DD axon pathfinding:  A VD/DD commissural axon that 
failed to reach the dorsal nerve cord or that wandered laterally before reaching 
the dorsal nerve cord was considered mutant.  The percent of animals with 
pathfinding defects was noted, and the percentage of defective axons was noted.  
VD cell body displacement:  The VD neurons are descendants of the P cells.  If 
the P nuclei fail to migrate ventrally, the resulting VD cell bodies can be laterally 
displaced out of the ventral nerve cord.  The percentage of animals with laterally 
displaced VD cell bodies was scored. AVM axon pathfinding: The AVM cell body 
is situated laterally on the right side, in the anterior half of the body of the animal. 
The axon extends ventrally towards the ventral nerve cord, which then extends 
anteriorly until the first pharyngeal bulb. Similarly to PDE axons, if the axon failed 
to reach the ventral nerve cord or wandered beyond a 45o angle from a straight 
line ventrally, it was considered mutant. Significance was determined using 
Fisher Exact Analysis. 
 
Activated cdc-42(G12V), myr::unc-40(cyto), myr::unc-73(DH/PH) and 
myr::tiam-1(DH/PH) transgenes. The cdc-42(G12V) transgene under the 
control of the osm-6 promoter was used similarly to as described previously for 
ced-10(G12V) (Struckhoff and Lundquist 2003).  A myr::unc-40(cyto) transgene 
under the control of the mec-7 promoter was used as described in Gitai et 
al.,2003. The myr::GEF(DH/PH) transgenes under the control of the osm-6 
promoter was used as means of overactivating the GEF. The catalytic DH/PH 
domains can potentially be inhibited intra- or inter-molecularly. By cloning out the 
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DH/PH domains, we are potentially relieving any sort of intra-molecular inhibition, 
and any other inter-molecular inhibitory mechanisms that would include other 
portions of the molecule (eg., if an inhibitor binds another domain of the GEF to 
inhibit the DH/PH domains). The myristoylation sequence was added N-
terminally to ensure the construct would reach the plasma membrane. 
 
TIAM-1 and CED-10 transgenes.  The WRM0633ch01 fosmid (Geneservice) 
containing the full-length tiam-1 transgene, with its entire upstream and 
downstream regions (past the poly-A addition site), was used for the first rescue 
experiment. The cmv::mCherry::tiam-1 fusion construct were generated by PCR 
amplifying the entire tiam-1 coding region based on the H9 cDNA (courtesy of 
Yuji Kohara). The tiam-1 construct was placed under the CMV promoter and 
fused N-terminally with mCherry by cloning the tiam-1 coding gene into the 
pTriEx-mCherry (kindly provided by the Hahn lab). A similar tiam-1 coding region 
construct was also amplified without the stop codon. This construct was fused C-
terminally in frame to the worm mCherry gene, and placed under the osm-6 or 
unc-25 promoters. The gfp::ced-10 transgene was built by PCR amplification of 
the ced-10 cDNA and cloned into the pEGFP-C1 vector (Clonetech), which fused 
the ced-10 coding region N-terminally to gfp. 
 
Cell culture, transfections and co-localization assays in NIH3T3 fibroblasts. 
NIH 3T3 mouse fibroblasts were grown in DMEM (Cellgro) supplemented with 
10% Cosmic Calf serum (HyClone) and 1% penicillin-streptomycin (P/S) and 
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maintained in 5% CO2 at 37°C. Cells were plated onto coverslips the day before 
transfection at a density of 200,000 cells per well in a 6-well plate. For co-
localization assays, pEGFP-C1 (vector only, “GFP”), pEGFP-C1 expressing 
CED-10 (“GFP::CED-10”), pTriEx-mCherry (vector only, “mCherry”) and pTriEx-
mCherry expressing TIAM-1 (“mCherry::TIAM-1”) were transiently transfected 
into NIH3T3 cells using GeneExpresso Transfection reagent (Lab Supply Mall) 
according to the manufacturer's specifications. To visualize subcellular protein 
localizations at high magnification, the NIH 3T3 cells grown on coverslips and 
transiently transfected were fixed in 3.7% formaldehyde for 1 h at room 
temperature. Coverslips were then washed three times in 1× Phosphate Buffered 
Saline (PBS), one time in ddH2O, and then mounted onto a glass slide using 
ProLong Gold antifade (Invitrogen/Molecular Probes) mounting medium. The 
cells were then visualized using compound fluorescence microscopy (a Leica 
DMRE microscope with a Qimaging Rolera MGi EMCCD camera was used along 
with the IPLab and ImageJ softwares). 
 
Mant-GTP based exchange assay. We amplified the DH-PH domains of TIAM-
1 (based on the H9 cDNA) (aminoacids 488 till 856), placed it into the pET-28b 
vector (Novagen), which has a T7 IPTG-inducible promoter and a C-terminal 
6HIS-tag, and transformed this construct into BL21(DE3) Gold competent cells 
(Agilent Technologies). For the TIAM-1[DH(Thr-08-Phe)/PH] construct, we 
designed primers to make a point mutation in the wild-type construct using the 
QuickChange kit (Stratagene). We purified TIAM-1[DH/PH]::6HIS using Ni-
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column based chromatography. For the mant-GTP assay, we used the RhoGEF 
Exchange Assay Biochem Kit (Cytoskeleton). Experiments were performed as 
described in the Cytoskeleton manual. We used 12.5µM of TIAM-1[DH/PH] in our 
experiments. 
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Figure 4.1 
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Figure 4.1 Gene and protein sequence and structure of TIAM-1. A Top lane – 
protein sequence of the TIAM-1 protein. Bottom lane - coding region of the tiam-1 
gene. Both sequences are based on the longest (h9) cDNA. The putative 
EVH1/PH and PDZ domains, along with the predicted DH and PH domains, are 
highlighted in the protein sequence in shades of gray. The two deletion alleles, 
tm1556 and ok772, are highlighted in the DNA sequence in black. B 
Representative schemes of the tiam-1 gene. All three cDNAs obtained (h9, a10 
and f12) were sequenced and served as models for the three gene structures 
presented. Black boxes – exons. White boxes – untranslated regions. Both 
deletion alleles (tm1556 and ok772) are depicted underneath the structures, 
demonstrating the deletion span in the gene. C Representative schemes of the 
TIAM-1 protein. The h9-cDNA-based protein has a putative EVH1/PH N-
terminally, followed by a putative PDZ domain and the RacGEF DH/PH domains. 
Both a10- and f12-cDNA-based proteins lack the putative EVH1/PH domain. The 
deletion alleles tm1556 and ok772 are depicted above the protein structures. D A 
representative scheme of the UNC-73 protein, based on its longest cDNA 
(F55C7.7a). UNC-73 has eight spectrin repeats,  RacGEF DH/PH domains, an 
Immunoglobulin domain (Ig),  RhoGEF DH/PH domains, and a Fibronectin 
TypeIII (FT3) domain. The point mutation allele rh40 is depicted above the 
protein structure. In both C and D, the protein length in amino-acid is shown to 
the right of the schemes. DH - Double Homology domain. PH - Pleckstrin 
Homology domain. PDZ – PSD95, DlgA, Zo-1 domain. EVH1 – Enabled/VASP 
Homology domain. 
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Figure 4.2 
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Figure 4.2. Rac GTPases and GEFs affect PDE axon pathfinding. A 
Percentage of PDE pathfinding defects in different genotypes shown. Both tiam-1 
alleles synergize with mig-2(mu28) and ced-10(n1993) to significant levels 
(p<0.01 as shown with *). Both tiam-1 alleles possibly add to the defects of unc-
73(rh40), without synergizing (p=0.2 as shown with ** when compared to unc-
73(rh40) alone). The double mutant mig-2(mu28); ced-10(n1993M+) is 
significantly different than any mutant combination (p=0.001 as shown with *). In 
all graphs, unless otherwise noted, n>100. B Fluorescent micrographs of wild-
type (wt) and mutant PDE neurons. 
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Figure 4.3 
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Figure 4.3. tiam-1 was expressed in and required for nervous system 
development. A Fluorescent micrographs of animals harboring a tiam-1p::cfp 
transgene. tiam-1 was expressed through the nervous system, including the 
depicted neurons. B Micrographs of animals harboring the zdIs4[mec-7p::gfp] 
transgene. A wild-type and tiam-1(ok772) mutant neuron (with an ectopic neurite) 
are shown. C Micrograph of an animal harboring the juIs76[unc-25p::gfp] 
transgene. The arrowhead points to a normal VD neuron, and the arrow points to 
a neuron that failed to extend properly until the ventral nerve cord in tiam-
1(tm1556). 
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Figure 4.4 
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Figure 4.4. Ectopic lamellipodia caused by overactive TIAM-1 and UNC-73 
was suppressed by loss-of-function of Rac GTPases. A Percentage of PDE 
neurons displaying ectopic lamellipodial and filopodial protrusions caused by 
overactive UNC-73 (MYR::UNC-73[DH1/PH1]) and TIAM-1 (MYR::TIAM-
1[DH/PH]). Both mig-2(mu28) and ced-10(n1993) suppressed these ectopic 
protrusions. * - p<0.001, ** - p<0.003. B Fluorescent micrograph of an animal 
harboring the integrated array lqIs123[osm-6p::myr::unc-73[DH1/PH1]. The arrow 
depicts an ectopic lamellipodial protrusion caused by this array. 
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Figure 4.5 
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Figure 4.5. TIAM-1 and CDC-42 act cell-autonomously in a linear pathway. A 
Percentage of PDE axon pathfinding defects. tiam-1(ok772) and cdc-
42(gk388M+) have similar penetrance of defects as cdc-42(gk388M+) alone. 
unc-73(rh40) and cdc-42(gk388M+) synergize in axon pathfinding defects. B 
Constitutively activated CDC-42(G12V) expressed in PDE neurons displays 
ectopic lamellipodial protrusions that are suppressed by the lack of tiam-1. As a 
control, we introduced a fosmid containing the tiam-1 gene back as an extra-
chromosomal array (tiam-1(+)), and this array rescued the ectopic lamellipodia in 
this animals. C tiam-1 acts cell autonomously in the PDE neurons for the ectopic 
lamellipodial protrusions caused by CDC-42(G12V). Two injected lines of the 
cDNA amplified coding region of tiam-1 placed under the osm-6 promoter were 
injected at different concentrations. Both rescued the incidence levels of 
lamellipodia in the absence of either allele of tiam-1. In all graphs, * - p<0.001; 
NS – not significantly different from cdc-42(gk388M+) (A) or cdc-42(G12V) (B). 
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Figure 4.6 
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Figure 4.6. TIAM-1 localizes to the cell body periphery, and is present in 
neurites and in the VD growth cones. A Micrographs of animals carrying an 
osm-6p::tiam-1::mCherry array. TIAM-1 is excluded from the nucleus and is 
possibly associated with the plasma membrane in the cell bodies of the PDE 
neurons. B Micrographs of animals carrying an unc-25p::tiam-1::mCherry array. 
Similarly to the PDE neurons, TIAM-1 seems to be associated with the plasma 
membrane of the cell body of these neurons. TIAM-1 is also present in the axons 
and dendrites of both PDEs and VD neurons. C TIAM-1 is present in the growth 
cones of growing VD neurons. 
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Figure 4.7 
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Figure 4.7. TIAM-1 co-localized with CED-10 in certain domains of NIH 3T3 
plasma membrane. A Fluorescent micrographs of NIH 3T3 cells expressing 
GFP (vector only), mCherry (vector only), GFP::CED-10 and mCherry::TIAM-1. 
Arrowheads depict protein accumulation by the plasma membrane. B Co-
transfection of GFP::CED-10 (in red) and mCherry::TIAM-1 (in green) show these 
two proteins co-localize in certain domains of the plasma membrane (depicted by 
the arrows). 
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Figure 4.8 
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Figure 4.8. TIAM-1[DH/PH] catalyzed the incorporation of mant-GTP by 
Rac1, but not Cdc-42 nor RhoA. A-D Arbitrary fluorescence units representing 
the amount of fluorescence emitted by mant-GTP over the period of 30 minutes. 
Light-colored lines represent the assay with the addition of 12.5µM wilt-type 
TIAM-1[DH/PH] or mutant TIAM-1[DH(Thr-08-Phe)/PH] after five minutes of 
incubation (dotted vertical line). Dark-colored lines represent addition of vehicle 
after five minures of incubation (dotted vertical line). All reactions were incubated 
for five minutes with mant-GTP, reaction buffer and GTPase. A Human Rac1 is 
used as substrate. After the addition of wild-type TIAM-1[DH/PH] to Rac1, mant-
GTP-derived fluorescence increases dramatically to around 2-fold. The mere 
addition of vehicle does not change the overall fluorescence of the reaction. B 
and C Cdc-42 and RhoA were used as substrates, respectively. The addition of 
wilt-type TIAM-1[DH/PH] did not change the mant-GTP-derived fluorescence of 
the reaction. D The addition of mutant TIAM-1[DH(Thr-08-Phe)] did not affect the 
fluorescence levels overall in the assay. For all reactions, n=3. 
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Figure 4.9 
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Figure 4.9. tiam-1 acts downstream of unc-6/Netrin, in parallel to slt-1/Slit 
and vab-1/Ephrin. A Percentage of PDE axon pathfinding defects in different 
guidance mutants. tiam-1(ok772) increased the defects seen in axon pathfinding 
of vab-1(dx31) (* p<0.001) and slt-1(eh15) (** p<0.1) mutants, but not in unc-
6(ev400) animals. B Percentage of lamellipodial and filopodial protrusions 
caused by overactivated MYR::UNC-40(cyto) in AVM neurons. tiam-1(ok772) 
significantly suppresses such defects (* - p<0.001), while unc-73(rh40) does not 
have an effect. C Fluorescent micrographs of a wild-type and a mutant myr::unc-
40(cyto) AVM neuron. The arrow depicts an ectopic lamellipodial protrusion 
coming out of the cell body. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 153 
Figure 4.10 
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Figure 4.10. A model of the molecules involved in the UNC-6/Netrin 
attractive signaling pathway. The ligand UNC-6/Netrin binds to its receptor 
UNC-40/DCC in the plasma membrane of the growth cone. Upon binding to its 
ligand, UNC-40/DCC activates the CDC-42-TIAM-1 pathway for the activation of 
the Rac GTPases MIG-2/RhoA and CED-10/Rac, in parallel to the UNC-73/Trio 
Rac activation pathway, in axon pathfinding. 
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Figure 4.S1 
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Figure 4.S1. TIAM-1 has putative EVH1 and PDZ domains. A and B BLAST 
alignments of the predicted EVH1 regions of C. elegans TIAM-1 (Ce) (this work), 
Still life/Tiam1 from Ascaris suum (As) (GenBank: ADY42014), and Still 
Life/Tiam1 isoform E from Drosophila melanogaster (Dm) (Genbank 
NP_001097519). C ClustalW alignment of the predicted EVH1 and PDZ domains 
of the same molecules mentioned above A and B. 
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Chapter V 
A Genetic Screen of DH-Containing Guanine-Nucleotide Exchange Factor 
Genes Reveals that in addition to UNC-73/Trio and TIAM-1, PIX-1/βPIX, UIG-
1/Clg and EXC-5/FGD1 also participate in PDE Axon Pathfinding 
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5.1. Abstract 
 In C. elegans axon guidance, UNC-73/Trio is a well established GEF for 
the two redundant Rac GTPases MIG-2 and CED-10. Nevertheless, there is 
compelling evidence UNC-73/Trio is not the only GEF controlling the Rac 
GTPases in this process. We performed a candidate-approach genetic screen 
with the other 18 DH-containing GEF genes in the C. elegans genome, and 
found that besides UNC-73/Trio and TIAM-1 (another GEF known to act in 
parallel, but not redundantly, to UNC-73), one other Rac-specific GEF (PIX-
1/βPIX) and two CDC-42-specific GEFs (UIG-1/Clg and EXC-5/FGD1) also have 
a role in PDE axon pathfinding. 
 Genetic data suggests PIX-1/βPIX acts redundantly with UNC-73/Trio, in 
parallel to CDC-42 and TIAM-1, in the control of the Rac GTPases. Also, UIG-
1/Clg possibly acts in the CDC-42 and TIAM-1 upstream of MIG-2/RhoG and 
CED-10/Rac. Finally, our EXC-5/FGD1 results suggest this molecule acts in 
parallel to MIG-2/RhoG in axon pathfinding. 
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5.2. Introduction 
Rac GTPases are key regulators of the actin cytoskeleton (Hall 1998; 
Bishop and Hall 2000). Like other members of the Rho subfamily of small 
GTPases Cdc-42 and Rho, Racs are active when bound to GTP and inactive 
when bound to GDP (Bar-Sagi and Hall 2000). Guanine-nucleotide exchange 
factors (GEFs) aid in the exchange of GTP for GDP. GEFs facilitate the exit of a 
GDP molecule from the GTP-binding pocket of Rac. Since the concentration of 
GTP inside the cell is much higher than that of GDP, a GTP molecule can then 
enter the Rac GTP-binding pocket and activate the molecule (Schmidt and Hall 
2002).   
Rac GTPases have been implicated in many different aspects of cell 
migration and neurite extension (Dickson 2001). Both cell and growth cone 
migration require the constant extension and retraction of cell processes (i.e., 
filopodia and lamellipodia), and the regulation or adhering molecules (such as 
cadherins and integrins) (Huber, Kolodkin et al. 2003). Failure in the proper 
extension or retraction of cell protrusions in axonal development may lead to 
improper axon extension and guidance (Prasad and Pasterkamp 2009). 
The peripheral actin cytoskeleton is the main constituent of lamellipodial 
and filopodial extensions. In lamellipodia, the actin cytoskeleton is primarily 
architected in 70o angle branches that spread around the protrusion, yielding in 
an actin filament meshwork. In filopodia, actin filaments bundle together to yield 
in the pointy-like structures that are the basis for these finger-like protrusions 
(Dent and Kalil 2001; Dent and Gertler 2003). The precise control of actin-binding 
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proteins is of vital importance for the modulation and occurrence of these cellular 
processes (Machesky and Insall 1998). Actin-modulating proteins such as 
formins, the Arp2/3 complex, UNC-115/abLIM, capping and anti-capping proteins 
(such as Enabled), and many others have specific and sometimes overlapping 
functions during the development of lamellipodia and filopodia (Lundquist, 
Herman et al. 1998; Dong, Pruyne et al. 2003; Norris, Dyer et al. 2009). Formins, 
Arp2/3 complex and possibly UNC-115/abLIM are involved in the polymerization 
of actin-filaments, most likely in different aspects (for example, Arp2/3 could have 
a greater role in the modulation of the actin meshwork present in lamellipodia, 
while formins and UNC-115/abLIM could act in the bundling and polymerization 
of actin in filopodia) (Dong, Pruyne et al. 2003; Yang and Lundquist 2005; 
Beltzner and Pollard 2007). The capping and anti-capping proteins regulate actin 
polymerization at the tips of actin filaments, by preventing and allowing, 
respectively, actin-monomers to be added to these ends (Bashaw, Kidd et al. 
2000). 
Many of these actin-modulating proteins – the Arp2/3 complex and UNC-
115/abLIM for instance – are Rac GTPase effectors (Struckhoff and Lundquist 
2003; Shakir, Jiang et al. 2008). While much is known about downstream 
effectors of Rac GTPases in axon guidance in vivo, not as much is known about 
their upstream regulators. In Caenorhabditis elegans axon pathfinding, loss-of-
function mutations in either ced-10/Rac or mig-2/RhoG alone did not cause 
significant defects in the PDE ventrally-guided model neurons, nor in the VD and 
DD dorsally-guided model neurons. However, a double mutant combination of 
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mig-2;ced-10 resulted in misguided axons in almost every PDE and VD/DD 
neuron, indicating Rac GTPase activity is crucial for this process (Lundquist 
2003). 
UNC-73/Trio is a well characterized Rac GEF for the two redundant Rac 
GTPases CED-10/Rac and MIG-2/RhoG (Lundquist, Reddien et al. 2001). This 
GEF has two Double Homology (DH) and Pleckstrin Homology (PH) domain 
sets, which are the domains that have guanine-nucleotide exchange activity. The 
first DH/PH set of UNC-73/Trio has been biochemically and genetically 
characterized as Rac-specific, while the second DH/PH set is Rho-specific 
(Figure 5.1) (Steven, Kubiseski et al. 1998). A point mutation that changes a 
serine to a phenylalanine in the first, Rac-specific DH/PH set of UNC-73/Trio 
(rh40) disrupted significantly axon pathfinding of both PDE and VD/DD neurons, 
but not as severe as the double Rac GTPase mutant mig-2;ced-10 (Lundquist, 
Reddien et al. 2001) . Therefore, we hypothesized other upstream activators of 
Rac GTPases might be needed for the proper control of axon pathfinding in 
these neurons. 
We searched in the C. elegans genome for all genes that would encode a 
DH-containing molecule. Besides UNC-73/Trio, there are 18 other predicted DH-
containing molecules in the nematode genome. We then obtained loss-of-
function alleles or RNAi constructs to down-regulate the function of these 18 
genes alone and in combination with either mig-2/RhoG or ced-10/Rac, and we 
analyzed the PDE morphology of these mutants (Table 5.1). 
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DH domains are not specific for Rac GTPases only, but for all proteins of 
the family of the Rho subfamily of small monomeric GTPases (Schmidt and Hall 
2002). From these 18 genes, seven contained a predicted Rac-specific DH 
domain, six contained a predicted Rho-specific DH domain, seven with a 
predicted Cdc-42-specific DH domain, one with a Ras-specific DH domain, and 
one with a DH domain of predicted specificity (Table 5.1). 
In this report, we provide evidence that besides UNC-73/Trio and TIAM-
1/Still life (see chapter IV), one other Rac-specific GEF (PIX-1/βPIX) and two 
other Cdc-42-specific GEFs (UIG-1/Clg and EXC-5/FGD1) interacted genetically 
with either MIG-2/RhoG or CED-10/Rac in PDE axon pathfinding (Figure 5.1 and 
5.2). 
 
5.3 Results 
 
The Rac GEF PIX-1/βPIX acts with MIG-2/RhoG and CED-10/Rac in PDE 
axon pathfinding. PIX-1 (PAX [p21-activated kinase] interacting exchange 
factor) if the C. elegans counterpart of β-PIX, a Rac-specific GEF implicated in 
many aspects of cellular and neuronal development, including cell migration and 
lamellipodial protrusiveness (Ciani and Salinas 2008). In C. elegans, PIX-1 
signals in a complex with GIT and PAK independently of Rac and CDC-42 in 
distal tip cell migration (Lucanic and Cheng 2008). Nevertheless, in the migration 
of Q-neuroblast descendent neurons, PIX-1 has been implicated in acting with 
CED-10/Rac, in parallel with MIG-2/RhoG and UNC-73/Trio (Dyer, Demarco et 
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al. 2010). We investigated the role of PIX-1/βPIX in PDE axon pathfinding. The 
loss-of-function mutation pix-1(ok982) is a one base-pair insertion (A) and 
1002bp deletion that removes amino-acids 244-450, which include part of the DH 
domain of the molecule. In the ventrally guided post-deirid sensory set of PDE 
neurons, pix-1(ok982) did not display significant defects in axon pathfinding 
compared to wild type (1%) (Table 5.2). However, in combination with either mig-
2(mu28) or ced-10(n1993), pix-1(ok982) increased the penetrance of defects 
significantly to 19% and 19.6% respectively (p<0.001 in both cases). The loss-of-
function allele unc-73(rh40) displayed a similar trend of increased PDE 
pathfinding defects when in combination with either mig-2(mu28) or ced-
10(n1993). Therefore, PIX-1/βPIX could act similarly to UNC-73/TRIO with both 
Rac GTPases. 
PIX/βPIX acts redundantly to UNC-73/Trio in PDE pathfinding. Because pix-1 
displayed similar genetic interactions with mig-2 and ced-10 to unc-73, we 
investigated if these two GEFs also interact genetically. unc-73(rh40) mutants 
displayed 42% of PDE guidance defects. In a double mutant pix-1(ok982); unc-
73(rh40) background, 77% of PDE neurons had disrupted axons (p<0.001) 
(Table 5.2). Such results are quite similar to what mig-2(mu28); ced-
10(n1993M+) mutant animals displayed (84%), suggesting UNC-73/Trio and 
PIX/βPIX could be acting redundantly to control the activity of MIG-2/RhoG and 
CED-10/Rac1 in PDE axon pathfinding. 
The other Rac GEF known to participate in PDE axon pathfinding, TIAM-1, 
acts in parallel, but not redundantly, to UNC-73/Trio (Chapter IV). Contrary to the 
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results with pix-1, loss-of-function mutations in both tiam-1 and unc-73 increased 
PDE axon guidance defects observed in an additive rather than synergistic 
manner, suggesting a non-overlap of functions between these molecules. 
Similarly to unc-73(rh40), mutations in both pix-1(ok982); tiam-1(ok772) 
displayed a possibly additive increase in PDE axon pathfinding defects (4%) 
(p=0.99 when compared to addition q=0.0399; p=0.17 when compared to either 
mutant alone) (Table 5.2). 
In addition, TIAM-1, but not UNC-73/Trio, was required for the ectopic 
lamellipodia caused by the overactivation of CDC-42 in PDE neurons. We then 
investigated whether PIX-1 was required for such a phenotype. 
CDC-42, another member of the Rho subfamily of small GTPases, can be 
constitutively activated by a Glycine-12-Valine substitution in the GTP-binding 
pocket of the molecule. This mutation favors the GTP-bound state of the 
GTPase, hence activating it. Animals harboring the cdc-42(G12V) construct 
displayed 42% of their PDEs with ectopic lamellipodial projections. Like unc-
73(rh40) animals, pix-1(ok982) did not suppress this phenotype (47% for unc-73, 
82% for pix-1) (Table 5.3). In fact, pix-1(ok982) mutants significantly increased 
the lamellipodia observed (p<0.001), consistent with the hypothesis these two 
molecules (CDC-42 and PIX-1) act in different, parallel pathways. 
 
PIX-1/βPIX can act with CED-10/Rac in parallel to MIG-2/RhoG in VD and DD 
axon pathfinding. In the dorsally attracted GABAergic VD and DD 
motorneurons, some of the intracellular machinery used for their guidance is 
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shared with the ventrally guided PDE neurons. ced-10(n1993) and mig-2(mu28) 
mutants disturbed pathfinding weakly (2.31% and 3.85%, respectively), but in 
combination, mig-2(mu28); ced-10(n1993M+) affected every VD and DD axon 
(100%, p<0.001) (Table 5.4). unc-73(rh40) displayed 26.15% defects alone, and 
synergistically increased the defects of mig-2(mu28) to 55.28% (p<0.001). 
Similarly, unc-73(rh40); ced-10(n1993M+) displayed 47.79% of VD/DD axon 
defects (p<0.001). Hence also in the VD and DD motorneurons UNC-73/Trio 
interacts with both MIG-2/RhoG and CED-10/Rac for proper axon pathfinding. 
We decided to investigate the role of PIX-1 in these neurons. Alone, pix-
1(ok982) displayed 3.08% of VD and DD commissural axon pathfinding defects. 
pix-1(ok982) additively increased the defects seen in a mig-2(mu28) background 
to 16.15% (p=0.23 when compared to addition q=0.0681; p<0.001 when 
compared to either mutant alone), suggesting these two molecules are acting in 
a parallel but not redundant pathway. However, pix-1(ok982); ced-10(n1993M+) 
animals displayed 1.54% of pathfinding defects, which was not statistically 
different from either mutant alone (p>0.4). With unc-73(rh40), pix-1(ok982) also 
did not increase significantly the defects observed (26.67%, p=0.92) (Table 5.4). 
These results suggest PIX-1/βPIX could act with CED-10/Rac, in parallel to MIG-
2/RhoG, for VD and DD axon pathfinding. Though MIG-2/RhoG and CED-10/Rac 
act redundantly in this process, they are also known to have different, specific 
effects during neuronal development. Therefore, it could be that PIX-1/βPIX acts 
with CED-10/Rac in a specific process of axon pathfinding (for example, a 
pathway involving PIX-1/CED-10 could act to promote filopodia and lamellipodia 
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extension during growth cone migration, while another one involving UNC-
73/MIG-2/CED-10 could act to promote protrusion retraction). Future studies will 
aim to identify the cellular basis of these differences by growth cone dynamics 
analysis. 
 
UIG-1/Clg could act with CDC-42 and TIAM-1 to control Rac GTPases in 
PDE pathfinding. UIG-1 (UNC-112-Interacting GEF) is a novel CDC-42-specific 
GEF that in body wall muscle forms a complex with UNC-112/Mitogen inducible 
gene-2 and PAT-3/β-integrin to regulate PAT-3-mediated adhesive structure 
(Hikita, Qadota et al. 2005). UIG-1 is similar to human common site 
lymphoma/leukemia GEF (Clg), a molecule implicated in pancreatic and breast 
cancers (Himmel, Bi et al. 2002). Both CLG and UIG-1 have been shown to 
biochemically activate Cdc-42, but not Rac nor RhoA (Himmel, Bi et al. 2002; 
Hikita, Qadota et al. 2005). In C. elegans, uig-1(ok884) is a 1337bp deletion that 
removes part of the DH domain and virtually the entire PH domain that follows it 
(ok884 deletes aminoacids 358-535). uig-1(ok884) did not display any PDE 
pathfinding defects on their own, but increased the defects seen in a mig-
2(mu28) background to 11% (p=0.003), and in a ced-10(n1993) to 7% (p=0.007) 
(Table 5.5). In addition, uig-1(ok884); unc-73(rh40) animals had 66% of their 
PDEs affected (p=0.001), which suggests UIG-1/Clg1 and UNC-73/Trio act in 
parallel pathways.  
Accordingly with this idea, UIG-1/Clg1 could act with CDC-42 and TIAM-1 
act in a linear pathway. uig-1(ok884); tiam-1(ok772) mutants had only 3% of PDE 
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defects (p=0.3), and uig-1(ok884); cdc-42(gk388M+) displayed 13% of PDE 
pathfinding defects, which was not significantly different than cdc-42(gk388M+) 
alone (p=0.7). uig-1(ok884) also did not suppress the ectopic lamellipodia caused 
by the constitutively active cdc-42(G12V) (84%) (Table 5.6). These results 
suggest UIG-1/Clg1 acts upstream of CDC-42 in the control of TIAM-1 and the 
Rac GTPases. One intriguing result was that uig-1(ok884) not only did not 
suppress the ectopic lamellipodia caused by cdc-42(G12V) but significantly 
enhanced it. This could mean UIG-1/Clg1 could act in other pathways, possibly 
acting as a GEF for CDC-42-like proteins. Future studies will address this 
hypothesis by looking at GTPases that act redundantly with CDC-42. 
 
EXC-5/FGD1 putatively acts with CDC-42 and CED-10/Rac in PDE axon 
guidance. EXC-5 (Excretory Canal abnormal) is the C. elegans counterpart of 
human FGD1 (Facial Genital Dysplasia). FGD1 is a GEF for hCdc42 that, when 
mutated, causes Aarskog syndrome, with an impairment of proper skeletal 
development (Zheng, Fischer et al. 1996; Bedoyan, Friez et al. 2009). In C. 
elegans, EXC-5/FGD1 has been characterized to be involved in the development 
of the excretory canal (Gao, Estrada et al. 2001). The loss-of-function rh232 is a 
4564bp deletion that putatively abolishes protein translation. It removes the start 
codon plus the first 651 aminoacids, including its start and the DH and PH 
domains. In PDE neurons, exc-5(rh232) displayed 6% of pathfinding defects on 
its own, 8% when with ced-10(n1993) (p=0.6, a non significant change) and 23% 
when with mig-2(mu28) (p=0.001) (Table 5.5). exc-5(rh232); unc-73(rh40) had 
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54% of pathfinding defects, which did not increase significantly the defects of 
unc-73(rh40) alone or the addition of both mutant defects (p=0.2 when compared 
to addition q=0.4548). exc-5(rh232); cdc-42(gk388) displayed 22% of misguided 
axons, which is not significantly different then cdc-42(gk388) alone (p=0.3). In a 
combination with cdc-42(G12V), exc-5(rh232) failed to suppress the ectopic 
lamellipodia caused by this construct (37%, p=0.3) (Table 5.6). With tiam-
1(ok772), exc-5(rh232) displayed 9% of PDE pathfinding defects, a non-
significant increase (p>0.4 for both exc-5 alone or the addition q=0.0694). These 
results suggest EXC-5/FDG1 possibly acts in a linear pathway with CDC-42 and 
CED-10/Rac, in parallel to MIG-2/RhoG, during axon guidance. Interestingly, uig-
1(ok884); exc-5(rh232) double mutants displayed only 3% of PDE pathfinding 
defects (p=0.3) (Table 5.5). While we expected these two GEFs to act 
redundantly to modulate CDC-42, one could speculate these two GEFs could 
have differential effects, or that one (or both) could be acting non cell 
autonomously. Future work will aim to identify if autonomy is required in the PDE 
neurons for these molecules. 
 
5.4 Discussion 
 
PIX-1/βPIX is a Rac GEF that acts with MIG-2/RhoG and CED-10/Rac1 
redundantly with UNC-73/Trio in axon guidance. In the genetic screen for 
other GEFs that would act redundantly with UNC-73/Trio for the activation of 
MIG-2/RhoG and CED-10/Rac, PIX-1/βPIX was the only Rac-specific GEF that 
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seemed to act redundantly with UNC-73/Trio. The fact that the loss-of-function of 
pix-1 behaved similarly to unc-73 when in combination with mig-2 and ced-10, 
and that the double pix-1; unc-73 synergized in defects to very similar levels of 
the abolishment of Rac activity seen in mig-2; ced-10 animals suggest UNC-
73/Trio and PIX-1/βPIX might share the same role in the control of Rac GTPases 
during growth cone migration. In addition, the genetic interaction with tiam-1 
suggests PIX-1/βPIX, just like UNC-73/Trio, acts in a parallel but non-redundant 
pathway with this molecule. The current hypothesis is that TIAM-1 acts as a pro-
protrusiveness GEF, activating Rac GTPases to promote filopodia nad 
lamellipodia formation, while UNC-73/Trio acts in an opposite, anti-
protrusiveness pathway, stimulating Rac GTPases to retract filopodia and 
lamellipodia. PIX-1/βPIX might act with UNC-73/Trio in this retractive pathway. A 
more careful analysis of growth cone dynamics should enlighten the knowledge 
of what these molecules are doing during axon guidance. 
 
UIG-1/Clg putatively activates CDC-42 in the TIAM-1-mediated control of 
Rac GTPases. The role of CDC-42 in vivo in C. elegans axon pathfinding has 
not been wellh characterized as of yet. In the previous chapter, we have shown 
that TIAM-1 is an effector of CDC-42 in this process. In chapter III, we have also 
shown that the scaffolding protein RACK-1 is possibly acting downstream of 
CDC-42 with the acting binding protein UNC-115/abLIM and the serine/threonine 
kinase MIG-15/NIK in PDE guidance. During development, the PAR proteins act 
with PKC-3/aPKC upstream of CDC-42 to establish early embryo polarity. 
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In PDE axon pathfinding, we found UIG-1/Clg to interact with the Rac GTPases 
and possibly act in a linear pathway with CDC-42 and TIAM-1, the Rac GEF 
involved in the modulation of Rac activity in the UNC-6/Netrin pathway (Chapter 
IV). Our findings might reveal the path in which CDC-42 is activated in the 
nervous system. UIG-1/Clg possibly is the GEF utilized by the newborn neuron in 
order to activate CDC-42 and the TIAM-1/Rac pathway. In the future, we would 
like to assess if we can overactivate UIG-1/Clg in a similar manner we have 
activated TIAM-1 and UNC-73/Trio (Chapter IV) and test for suppression of 
overactivation by the loss of CDC-42 activity. 
 
The putative CDC-42 GEF EXC-5/FGD1 might act exclusively in the CED-
10/Rac1 pathway in parallel to MIG-2/RhoG in PDE axon guidance. Our 
genetic analysis revealed that EXC-5/FGD1 acts in parallel to the Rac GTPase 
MIG-2/RhoG in PDE axon pathfinding. Because MIG-2/RhoG and CED-10/Rac1 
act redundantly in this process, and mutations in exc-5 and ced-10 were not 
worse than exc-5 alone, we hypothesize these two molecules act in a linear 
pathway. Similarly, our results suggest EXC-5/FGD1 acts upstream of CDC-42 in 
the same pathway. Our genetic data in instances proved hard to be analyzed 
(i.e., mutations in unc-73 and exc-5 did not worsen mutations in unc-73 alone). 
Such phenomenon indicates that, when far away from each other in a certain 
pathway, molecules could branch out and have multiple effectors, making a 
simple genetic conclusion problematic. Nevertheless, we still have good 
evidence the putative CDC-42 GEF EXC-5/FGD1 acts in PDE axon pathfinding 
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with CDC-42 and the Rac GTPase CED-10 in parallel to MIG-2/RhoG. Future 
studies using overactivated EXC-5 (see Chapter IV) could help up better dissect 
this intricated pathway. 
From all the 19 genes screened in the C. elegans genome, we found five 
GEFs to play a role in PDE axon pathfinding. Nevertheless, we cannot exclude 
the possibility other GEFs are also used in this process. For instance, the Ras- or 
Rho-specific GEFs screened could have a role in axon pathfinding that is 
masked by redundancy with other more prominent GEFs. We did not conduct the 
screen with Ras or Rho, since these molecules do not seem to play a crucial role 
in PDE axon pathfinding and we were interested in molecules that participate in 
the Rac-mediated mechanisms of axon guidance. 
In sum, in support of the idea that multiple GEFs are implicated in the many 
different cellular events that involve the activation of Rho GTPases, five different 
GEFs (UNC-73/Trio, TIAM-1, PIX-1/βPIX, UIG-1/Clg and EXC-5/FGD1) are 
required for the Rac-mediated mechanisms of axon guidance. Three of them 
(UNC-73/Trio, TIAM-1 and PIX-1/βPIX) are Rac-specific GEFs that all seem to 
interact with MIG-2/RhoG and CED-10/Rac, though in different pathways (i.e., 
only TIAM-1 acts downstream of CDC-42). Two of them are CDC-42-specific and 
might also act in distinctive pathways (UIG-1/Clg potentially acts linearly with 
CDC-42 and TIAM-1 to control both CED-10/Rac and MIG-2/RhoG, while EXC-
5/FGD1 does not seem to act in the same pathway as MIG-2/RhoG). 
The magnificence of the cell biological mechanisms involved in the 
extension of an axon to its final target can be appreciated by the multitude of 
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pathways involved during this process. Rac GTPases have been known to act in 
axon guidance in diverse ways, including the polymerization of actin filaments in 
order to create filopodia and lamellipodia in the growth cone, and also in the 
retraction of such protrusions. Most likely, the diverse (and sometimes 
competitive) effects Rac GTPases accomplish during growth cone migration 
happen via a differential spatio-temporal recruitment and activation of the diverse 
GEFs present in the cell. Our results help elucidate some of the molecular 
combinations involved in this process. 
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5.5. Materials and Methods 
Please refer to section 2.4 in Chapter II for PDE axon pathfinding scoring, 
molecular biology techniques and C. elegans culture. 
The following mutations and genetic constructs were used:  LGI: unc-73(rh40), 
tiam-1(ok772), unc-89(st85), Y95B8a.12(ok1820), lqIs37[osm-6p::cdc-42(G12V)]; 
LGII:  cdc-42(gk388), ect-2(gk-44), tag-218(ok494), rhgf-2(gk216); LGIII: 
R02F2.2(ok1894); LGIV: ced-10(n1993), exc-5(rh232), tag-77(gk206), gei-
18(ok788), lqIs3[osm-6::gfp]; LGV:  uig-1(ok884), sos-1(cs41); LGX:  mig-
2(mu28), tag-52(gk162), rhgf-1(ok880), cgef-1(gk261), vav-1(ok425), pix-
1(ok982), lqIs2[osm-6::gfp]. 
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Table 5.1 
GEF Homology Specificity Synergy with mig-2 or ced-10 
UNC-73 TRIO Rac, Rho Yes 
TIAM-1 Tiam1, Still life Rac Yes 
PIX-1 βPIX, GEF7 Rac Yes 
UIG-1 Clg CDC-42 Yes 
EXC-5 FGD1 CDC-42 Yes 
ECT-2 Pebble, Ect2 Rho No 
TAG-218 Ephexin, Ngef Rho No 
TAG-77 Fgd family (Frabin) CDC-42 No 
TAG-52 Fgd family (Frabin) CDC-42 No 
RHGF-1 Leukemia-associated RhoGEF Rho No 
CGEF-1 Dbl’s Big Sister (Dbs) CDC-42 No 
RHGF-2 Unnamed, conserved Rho No 
VAV-1 Vav Rac No 
SOS-1 Son of Sevenless (Sos) Ras No 
UNC-89 Human Unc-89 Rac No 
GEI-18 Tuba Rac No 
R02F2.2 RhoGEF17 Rho No 
Y95B8a.12 Unnamed, converved CDC-42 No 
Y105E8A.24 Lymphoid blast crisis-like Rho, Rac No 
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Table 5.1. Summary of the DH-containing GEFs encoded by the C. elegans 
Genome and their interactions with Rac GTPases. The C. elegans GEF name 
of the protein (first column) is shown, followed by its homologous proteins in 
other systems (second column), the predicted specificity of its DH(s) domain(s) 
(third column), and the genetic results of the synergy experiments with either 
mig-2/RhoG or ced-10/Rac1 in PDE axon pathfinding (fourth column). 
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Table 5.2 
Genotype Percentage of PDE axon pathfinding defects 
mig-2(mu28) 1 
ced-10(n1993) 0 
pix-1(ok982) 1 
unc-73(rh40) 42 
tiam-1(ok772) 1 
mig-2(mu28); ced-10(n1993M+) 84 
pix-1(ok982) mig-2(mu28) 19 
pix-1(ok982); ced-10(n1993) 19.6 
pix-1(ok982); unc-73(rh40) 77 
pix-1(ok982); tiam-1(ok772) 4 
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Table 5.2. Percentage of PDE axon pathfinding defects in different genetic 
backgrounds. pix-1(ok982) significantly increased the defects of mig-2(mu28), 
ced-10(n1993), and unc-73(rh40). n=100 in all cases, unless otherwise noted. 
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Table 5.3 
Genotype Percentage of PDE ectopic lamellipodia 
cdc-42(G12V) 42 
unc-73(rh40); cdc-42(G12V) 47 
pix-1(ok982); cdc-42(G12V) 82 
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Table 5.3. Percentage of PDE axon ectopic lamellipodia incidence in 
different genetic backgrounds. Neither unc-73(rh40) nor pix-1(ok982) 
suppressed the ectopic lamellipodia caused by the overactivation of CDC-42. 
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Table 5.4 
Genotype Percentage of VD/DD pathfinding defects 
mig-2(mu28) 3.85 
ced-10(n1993) 2.31 
mig-2(mu28); ced-10(n1993M+) 100 
unc-73(rh40) 26.15 
unc-73(rh40); mig-2(mu28) 55.28 
unc-73(rh40); ced-10(n1993M+) 47.79 
pix-1(ok982) 3.08 
pix-1(ok982) mig-2(mu28) 16.15 
pix-1(ok982); ced-10(n1993) 1.54 
pix-1(ok982); unc-73(rh40) 26.67 
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Table 5.4. Percentage of VD and DD commissural axon pathfinding defects 
in different genetic backgrounds. pix-1(ok982) synergized with mig-2(mu28) 
but not ced-10(n1993) nor unc-73(rh40) in motorneuron axon pathfinding. In all 
cases, n>130. 
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Table 5.5 
Genotype Percentage of PDE axon pathfinding defects 
cdc-42(gk388M+) 15 
uig-1(ok884) 0 
exc-5(rh232) 6 
uig-1(ok884); mig-2(mu28) 11 
uig-1(ok884); ced-10(n1993) 7 
uig-1(ok884); unc-73(rh40) 66 
uig-1(ok884); tiam-1(ok772) 3 
uig-1(ok884); cdc-42(gk388M+) 13 
exc-5(rh232); mig-2(mu28) 23 
exc-5(rh232); ced-10(n1993) 8 
exc-5(rh232); unc-73(rh40) 54 
exc-5(rh232); tiam-1(ok772) 9 
exc-5(rh232); cdc-42(gk388M+) 22 
exc-5(rh232); uig-1(ok884) 3 
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Table 5.5. Percentage of PDE axon pathfinding defects in different genetic 
backgrounds. uig-1(ok884) and exc-5(rh232) displayed a role in PDE axon 
pathfinding when interacting with the Rac GTPases and their regulators. 
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Table 5.6 
Genotype Percentage of PDE ectopic lamellipodia 
cdc-42(G12V) 42 
uig-1(ok884); cdc-42(G12V) 84 
exc-5(rh232); cdc-42(G12V) 37 
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Table 5.6. Percentage of PDE axon ectopic lamellipodia incidence in 
different genetic backgrounds. Neither uig-1(ok884) nor exc-5(rh232) 
suppressed the ectopic lamellipodia caused by the overactivation of CDC-42. 
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Figure 5.1 
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Figure 5.1. Protein structure representations of the five GEFs that 
interacted with the Rac GTPases in PDE axon pathfinding. The loss-of-
function alleles of the genes used are represented with a dash, indicating where 
the point mutation (rh40) or deletions would be if a protein is produced. In all five 
cases, at least the DH domain is affected by the mutation. GEF specificity for 
either Rac or CDC-42 is depicted underneath the correspondent DH domain. 
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Figure 5.2 
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Figure 5.2. Fluorescent micrographs of PDE neurons in different genetic 
backgrounds. pix-1(ok982), uig-1(ok884) and exc-5(rh232) interact genetically 
with mig-2(mu28) and ced-10(n1993) in axon guidance. 
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